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Signal transduction pathways in macrophages activated by lipopolysaccharide (LPS) are
only beginning to be elucidated. The first step involves recognition o f LPS by the cells
primarily by the LPS receptor, CD 14. Different LPS and lipid A preparations, as well as
lipoteichoic acids from Gram positive organisms, bind to CD 14 and activate signaling.
However, they showed a wide range o f potencies in activating arachidonic acid
metabolism. These data combined with current theories on supramolecular
conformations o f bacterial amphiphiles, suggest a. model o f potency based on aggregate
conformation and the availability o f monomers for binding to CD 14. Although not
conclusive, this model provides a basis for exploration of variations in responsiveness to
bacterial amphiphiles.
Ceramide is an important second messenger in immune cells, and it appears to share
signaling components with LPS pathways. Studies on the hypothesis that LPS acts by
mimicking ceramide have provided many clues to mechanisms o f intracellular
modulation o f responsiveness. LPS and ceramide both activated arachidonic acid
metabolism, but only LPS induced the production o f prostaglandin E 2. This suggests a
divergence in signaling pathways that may be related to pool compartmentalization of the
signaling enzymes or their substrates. LPS, but not ceramide, was able to desensitize
cells to subsequent challenge. This difference could either be due to a lack of a shared
regulatory mechanism, or to an autocrine/paracrine effect related to the activation of
prostaglandin production.
Responsiveness is also determined by the phosphorylation state o f tyrosine kinases of
the src family. CD45 protein tyrosine phosphatase was shown to be involved in LPSinduced signaling through the use o f anti-CD4S monoclonal antibodies. Although the
antibodies and their isotype controls had little or no effect on their own, anti-CD45
significantly increased ( 2 -fold) the release o f arachidonic acid metabolites, including
prostaglandin E 2 following LPS challenge. This effect was shown to be primarily
involved in signaling through CD14, rather than CD 14-independent signaling.
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CHAPTER 1
OVERVIEW OF MACROPHAGE ACTIVATION AND DESENSITIZATION

The role of the macrophage in the vertebrate immune system.
The vertebrate immune system functions as a dynamic balance between states
of activation and states of tolerance, and many components of the system embody
mechanisms to respond to various signals in a discriminating manner. Errors in
discrimination or deviations in the delicate balance can lead to responses that are
damaging to the organism. If poorly responsive, the immune system is ineffective in
its protective role, but if overly responsive it can induce pathological consequences.
Macrophages have proven to be at the hub o f this process, playing significant roles in
both cellular and humoral immune responses. They are large, adherent, mononuclear
phagocytic cells which differentiate from circulating monocytes and migrate into
various tissues. From this position o f influence, the macrophage’s activities must be
carefully regulated in order to maintain a balance o f responsiveness. Depending on
the stimulus, several different signaling pathways lead to a variety o f responses,
including cytokine release (especially TNFa, ILi, H*, ILg), oxidative burst, increased
phagocytosis, and arachidonic acid metabolism. Macrophage activation is being
studied regarding its involvement in multiple pathological responses including septic
shock, asthma, stroke, and atherosclerosis (5,13,71,81). It is therefore conceivable
that treatments or prevention of these diseases may evolve through the

1
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exploration o f mechanisms that influence the balance between the beneficial and
pathological sequelae o f macrophage activation.
Overview o f signal transduction pathways
In order to understand the mechanisms o f macrophage activation, it is necessary
to understand the basics o f signal transduction, which entails the ability of a cell to
detect and respond to extracellular signals. Signal transduction through cell surface
receptors can be categorized into three large general groups. In one well characterized
pathway, a transmembrane receptor activates a G (GTP-binding) protein, which then
alters the activity of adenylate or guanylate cyclase. Activation o f these enzymes
results in the generation o f second messengers, including cyclic adenosine
monophosphate (cAMP) or cyclic quanosine monophosphate (cGMP). In another
family o f pathways, the receptor activates a specific phospholipase C, which cleaves a
phosphodiester-linked side group from a phospholipid or sphingolipid. The cleavage
products, such as inositol triphosphate, diacylglycerol, or ceramide can then serve as
second messengers affecting a cellular response. Finally, some receptors activate
protein kinases and phosphatases which in turn can initiate the cellular response by
altering phosphorylation o f target proteins which are often enzymes or regulatory
elements. This is the primary signaling system used by the antigen-binding receptors
o f lymphocytes. Each o f these systems has mechanisms for shutting down the
response when the signal is no longer present or a second signal overrides the first.
Usually this is not a simple on/off switch, but rather a change in the balance or ratio
between opposing signals that affects the final outcome. Therefore, the activation
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state o f a cell depends on the expression of receptors, availability o f second
messengers, and the ability to shut down the response.
Definition of activation states
Studies have shown that macrophages respond very differently depending on
anatomical location, the nature of the stimulus, and the cell’s state o f differentiation.
Strictly speaking, macrophage activation states probably lie on a continuum
encompassing several hundred “forms of activation” (92). Attempts to characterize
them as macrophage subsets according to location or surface markers have been
unsuccessful (36). -For the purpose of this dissertation, only three states will be
defined. These are “responsive”, “activated”, and “desensitized”.
A responsive macrophage is competent to respond to signals. It might be
considered to be in a state o f vigilance, appropriate for the macrophage’s critical role
in detection. These cells respond to a stimulus by releasing high levels o f cytotoxic
and biologically active substances, many o f which serve to signal other cells. Stimuli
can include bacterial cell wall components, cytokines, and particles that are
phagocytized. The activated macrophage can be further stimulated with synergistic
signals and induced to release higher levels o f substances such as tumor necrosis
factor a (TNFa) and interleukins, but the mechanisms o f this additive response are not
clearly understood (1,17,39). However, it is the excessive or unbalanced production
o f these autocrine and paracrine mediators which has been implicated in multiple
disease states.
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The desensitization phenomenon
At the other end o f the continuum is a macrophage that has been desensitized and is
hyporesponsive. There are several mechanisms that may induce this state. A fairly
specific hyporesponsiveness is induced simply by saturating concentrations o f ligand
or the internalization o f receptors, making them unavailable for binding (17). This
requires a very specific receptor-ligand relationship, and the cell remains responsive to
other stimuli. Similarly, a means to down-regulate responsiveness to a specific
stimulus is to shed the receptor, and decrease its surface density (9). A more
generalized hyporesponsiveness is induced in macrophages by glucocorticoids ( 110 ).
The pathway is unclear, but it appears to be a natural mechanism for shutting down a
response by decreasing the activity o f enzymes such as the phospholipases. There is
some evidence that this involves phosphorylation or dephosphorylation (47), and/or
the release o f autocrine mediators (110). A third mechanism o f desensitization has
been demonstrated as a fairly specific hyporesponsiveness by macrophages to a
second exposure to bacterial cell wall amphiphiles such as lipopolysaccharide (LPS)
from Gram negative microorganisms (42,96), and lipoteichoic acid (LTA) from Gram
positive microorganisms (16). The state can be induced by concentrations o f LPS far
below saturation (17,28), and the cells remain responsive to other stimulators such as
phorbol myristate acetate (PMA) which bypass early steps in the signaling cascade
(16). This suggests that the mechanism o f desensitization is an early event that lies
between receptor binding and distal signaling. Others have provided some evidence
that the process requires the release o f autocrine mediators (28,41,76,84), although the
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data are not consistent enough to determine the precise factor(s) involved.
Desensitization is characterized by dramatic reductions in the amount o f products
released after subsequent challenge to, or below, constitutive levels.
Signal transduction in the activation of macrophages by LPS
Bacterial lipopolysaccharide (LPS) is a potent activator o f macrophages, but the
signal transduction pathways for its numerous effects have not been clearly defined.
LPS activates multiple pathways, resulting in the release o f cytokines, eicosanoids,
and oxygen free radicals. Macrophages have several surface binding proteins for LPS,
but only a few appear to be involved in signal transduction. In fact, they appear to be
able to respond to LPS via both receptor-dependent and receptor-independent
pathways (68,84,106,108). Differential activation of these pathways may depend on
the concentration o f LPS, its supramolecular structure as it is presented to the cells,
and/or the presence o f LPS binding proteins. Lipid A derivatives have been designed
that retain immunostimulatory properties, but lack endotoxicity. These remain able to
desensitize cells to LPS challenge, and are being explored as preventative treatments
for pathological inflammatory reactions.
The primary receptor for LPS actually appears to bind a complex consisting of
LPS and LPS binding protein (LBP). LBP is an acute phase protein found in the
serum, that binds LPS in an apparent 1:1 stoichiometry. This offers a unique way to
present LPS to cells. As an amphiphilic lipid, LPS is normally found in aggregates
such as micelles. The receptor, CD 14, is a glycosylphosphatidylinositol-linked
glycoprotein that has been shown to play a role in LPS-mediated macrophage
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activation (91,98) and desensitization (57,70). Since it lacks a cytosolic tail, it is still
unclear how it participates in signal transduction. However, CD 14 is among several
GPI-anchored proteins that are capable o f mediating cell activation when cross-linked
with monoclonal antibodies (67,88). CD 14 has also been shown to co-precipitate with
associated proteins (91). Deacylated LPS binds CD14, but does not elicit responses,
suggesting that another molecule associated with CD 14 is required to transduce the
signal (57). In fact, Vasselon, et al. have recently shown that trypsin treatment
reduced responsiveness to LPS in PMNs without any change in cell surface expression
o f CD 14 (95). It is possible, therefore, that there is a receptor complex on
macrophages which is analogous to the complexes on T cells and B cells. Signaling
following binding to CD 14 has been shown to include protein tyrosine
phosphorylation (43,60,98), release o f cytokines including TNFa, IL-1, and IL -6
(57,98), calcium fluxes and release of oxygen free radicals ( 6 6 ). Involvement of
CD 14 in the release o f eicosanoids is inferred by the dramatic increase in LPS-induced
release o f labeled arachidonic acid from THP-1 cells following induction of CD 14
expression (Fig. 7 in Chapter 2).
Arachidonic acid metabolism
Arachidonic acid, a C20 polyunsaturated fatty acid (C20:4) is commonly esterified
at the 571-2 position o f membrane glycerophospholipids. When released, usually by
phospholipase A2 (PLA2), arachidonic acid becomes a substrate for several metabolic
enzymes. Arachidonic acid and its family of metabolites constitute a very important
group o f paracrine and autocrine mediators called eicosanoids. Eicosanoids are
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rapidly released from macrophages following activation with various agents including
LPS and PMA. Two of the major eicosanoids released from macrophages are
prostaglandins (cyclo-oxygenase pathway) and peptidyl-leukotrienes (lipoxygenase
pathway) (31,33,48,105). The ratio o f these two lipid families appears to be important
in the regulation o f the immune response (100,105). Therefore, the study of
arachidonic acid metabolism in macrophages is critical to the understanding o f
regulatory mechanisms in the cellular immune response.
RESEARCH OBJECTIVES
This thesis focuses on the signal transduction leading to arachidonic acid
metabolism in THP-1 monocytic cells, with an emphasis on regulatory mechanisms
such as the desensitization phenomenon. Treatment strategies for inflammatory
responses associated with Gram negative bacterial infections have ranged from
palliative therapies, to cytokines given as pharmaceuticals, to monoclonal antibodies
generated against LPS. Despite promising results in in vitro studies and animal
models, none of these strategies has had much success in clinical studies to date. It
seems valid to explore regulatory systems already in place in the immune system as
possible mechanisms to exploit as therapeutic strategies. However, such studies will
require cell systems that provide good models for human macrophage activation, a
better understanding of how cells respond to LPS including specific signal
transduction pathways, and elucidation of those pathways’ regulatory mechanisms.
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Major Objective #1: Characterization of the human monocytic cell line, THP-1, as
an appropriate cell system for exploring macrophage activation, especially arachidonic
acid metabolism.
Specific Aims:

-

1. To study basic growth characteristics and determine ideal growth conditions.
2. To observe viability and morphological changes following treatments using
trypan blue exclusion and microscopy to determine that cell losses due to death or
adherence would not significantly impact assay results.
3. To measure lipid composition and pool labeling by thin layer
chromatography and liquid scintillation counting to demonstrate that treatments did
not cause alterations in these parameters that would impact assay results.
4. To measure surface expression o f CD14 using flow cytometry to determine
whether treatments affected expression o f this LPS receptor.
Major Objective #2. Compare the activation and desensitization of macrophages by
various bacterial amphiphiles, using the hypothesis that the supra-molecular structure
o f LPS and related molecules likely has an important influence on potency.
Specific Aims:
1. To measure 3H-arachidonic acid release from macrophages treated with
various forms o f LPS, lipid A, and LTA, the bacterial amphiphiles involved in septic
shock.
2. To demonstrate desensitization o f macrophages by these amphiphiles for
arachidonic acid metabolism and release o f pro-inflammatory cytokines.
3. To compare PGE2/LTC4 ratios released from treated cells, using EIA, to
determine whether patterns can be seen in terms o f the ability to desensitize cells to
subsequent challenge.

Major Objective #3. Compare the effects o f LPS and ceramide as activators o f
arachidonic acid metabolism, based on the current thinking that LPS may mimic
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ceramide as a second messenger. This model, if valid, would define many o f the
signal transduction components in LPS pathways that have otherwise proven elusive.
It could also be very important in the understanding o f septic shock syndrome due to
the induction o f apoptosis by ceramide and the recent evidence that a major part o f
septic shock is widespread endothelial apoptosis o f the micro vasculature of multiple
organs. Development o f the LPS/ceramide mimicry model has been based primarily
on studies o f cytokine release, and similarities between signaling by TNF and LPS. It
was therefore important to explore the model in terms o f arachidonic acid release.
Specific Aims:
1. To determine whether exogenous cell-permeable ceramides and/or
sphinomyelinase would activate arachidonic acid metabolism, and to compare that
with LPS activation.
2.

To measure PGE2/LTC4 ratios released following these treatments to
compare activation of these pathways (cyclo-oxygenase and S’-lipoxygenase).
3. To determine whether cell-permeable ceramide or sphingomyelinase could
desensitize cells to subsequent challenge.
4. To correlate eicosanoid ratios with the ability to desensitize.
Major Objective #4. Determine whether or not the CD45 protein tyrosine
phosphatase plays a role in the activation of macrophages by LPS. The hypothesis
was that CD 14 might be part of a receptor complex on macrophages similar to antigen
receptor complexes on T cells. CD45-deficient T cells are hyporesponsive to antigen
binding due to hyperphosphorylation o f the tyrosine kinases involved in the signaling
pathway. It seemed possible that phosphorylation- dephosphorylation dynamics might
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therefore play a role in the desensitization phenomenon in macrophages by a similar
mechanism.
Specific Aims:
1. To show expression of CD45 on THP-1 cells using flow cytometry, and to
determine whether LPS altered this expression either in terms o f percent o f cells
staining positive, or mean fluorescence.
2. To use specific monoclonal antibodies (mAb) to CD4S to determine their
effect, if any, on arachidonic acid metabolism and cytokine release induced by LPS,
either by binding or by being cross-linked.
3. To correlate CD45 involvement with signaling through the CD 14 pathways
by performing assays under conditions favoring this pathway, and by using an antiCD 14 mAb which binds the LPS binding site and activates the LPS pathways.
4. To determine whether CD45 plays a role in the desensitization phenomenon
by adding anti-CD45 mAb during the desensitization period of the assays.
5. To use Western blotting to detect changes in the phosphorylation state o f
CD4S on cells following treatment with LPS, since autodephosphorylation is an
indicator o f enzyme activity for CD45.
The experimental studies addressing these objectives are presented in the
following chapters.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

CHAPTER 2
Characterization of THP-1 Cells as a Human Macrophage Model for
Activation of Arachidonic Acid Metabolism
Introduction
Developing a model for studying macrophage activation is challenging due to the
heterogeneity o f this cell type and the difficulties of working in vivo. Although it must be
kept in mind that interactions between various cells types occur continuously under
normal circumstances, monocultures of monocytes derived either as primary cultures
harvested from blood or peritoneal fluid, or maintained as cells lines, can provide data
regarding direct effects of treatments in vitro, while holding most variables constant.
THP-1 is a human leukemic cell line with a normal diploid karyotype (29) that was
cultured initially from a boy with acute monocytic leukemia (90). These cells express
surface markers and respond similarly to human monocytes, and can be maintained in
monoculture as a nonadherent suspension with a doubling time o f 60 - 70 hours. They
can be differentiated to a more macrophage-like phenotype by treating them with various
agents, including phorbol myristate acetate (PMA), vitamin D3, or retinoic acid.
Differentiated THP-1 cells behave more like monocyte-derived macrophages than other
human myeloid cell lines, including HL-60, U937, KG-1, or HEL cells (4). THP-1 cells
must be maintained between 2 - 5 x 10s cells/ml and not used after approximately 20
passages due to losses in responsiveness. Most o f the work for this thesis was done using
THP-1 cells, but comparative studies were done on murine resident peritoneal

11
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macrophages harvested from Balb/C (Jackson Labs) mice, and RAW 264.7 cells. RAW
264.7 cells (ATCC) are virally-transformed mouse peritoneal macrophages that form
adherent monolayers in cell culture. They are well characterized as excellent models for
the study of murine macrophage activation (43,96). They were, however, of limited use
in studying arachidonic acid metabolism due to their constitutively high levels o f
arachidonic acid release.
There are very few good macrophage models, particularly for human cells. THP-1
cells were developed as a model for differentiation and expression o f monocytic surface
markers, but few studies have been done regarding their feasibility as a model for
inflammation and particularly for lipid metabolism. My objective for the studies
presented in this chapter was to characterize this cell line as a model for macrophage
activation, appropriate for studies focusing on arachidonic acid metabolism. This
included four specific aims. The first was to study basic growth characteristics and
determine ideal growth conditions in order to get the most consistent results. Second,
viability and morphological changes following treatments were observed using trypan
blue exclusion and microscopy to determine that cell loss due to cell death or adherence
would not significantly impact results. Third, we measured lipid composition and pool
labeling by thin layer chromatography to demonstrate that treatments did not cause
alterations of these parameters that would impact assay results. Finally, we measured the
surface expression of CD 14 using flow cytometry to determine whether treatments
affected expression o f this LPS receptor.
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MATERIALS AND METHODS

Amphiphiles and reagents. All LPS and lipid A preparations were provided by
Ribi ImmunoChem Research (Hamilton, MT). Stock solutions o f amphiphiles at 1000
pg/ml were kept at 4° C in 0.1% triethylamine (TEA). LTA from E. faecalis, PMA,
dexamethasone, N-acetyiceramide, phospholipid and sphingolipid standards for thin layer
chromatography, and 2-mercaptoethanol were obtained from Sigma. Vitamin D3 ( la , 25
dihydroxyvitamin D) was purchased from Calbiochem (LaJolla Ca). [3H]-arachidonic
acid was purchased from American Radiolabeled Chemical Co. (St. Louis, MO).
Minicolumns for lipid separations were purchased from Amersham. Monoclonal
antibodies for flow cytometry were from Becton-Dickinson Immunocytometry Systems
(San Jose CA) and Coulter Laboratories.
Cell Culture. THP-1 cells from ATCC were cultured in RPMI from Mediatech,
supplemented with 10% Hyclone fetal bovine serum (FBS) and 2 x 10'5 M 2mercaptoethanol at 37° C in a 5% CO 2 incubator. Cells were maintained between 2.5 x
10s and 1 x 106 cells/ml. Prior to experiments, cells were incubated overnight with a
maturation agent, either 10'7 M vitamin D3 or 2 nM PM A Although loosely adherent,
cells could be removed by pipeting or gentle scraping.
Lipid analysis. Lipids were extracted from THP-1 cells by a modification o f the
Bligh and Dyer procedure (12). THP-1 cells were grown in either 32P or 3H-AA (0.5
pCi/ml) to label the lipid pools. Cells were suspended in 1 ml cold NaCl (0.3%) and then
heated at 6 8 ° C in an additional 3 ml of solvent containing chloroform:methanol: 1 N HC1
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(1:2:0.3 v/v) for 5 min. The cooled suspension was centrifuged and the supernatant (lipid
extract) was transferred to a clean centrifuge tube The cell residue (pellet) was extracted
again with 1.9 ml o f solvent containing chloroformrmethanol: 0.3% NaCl ( 1 :2 :0 .8 v/v).
The combined extracts were mixed thoroughly with 1.5 ml chloroform and 1.5 ml 0.3%
NaCl. This mixture of chloroform:methanol:water (2:2:1.8 v/v) provided a two phase
system that was separated by centrifugation. The chloroform phase was removed and
taken to dryness, and resuspended in chloroform:methanol (2:1 v/v). Total lipid extracts
were analyzed by thin layer chromatography on Whatman LD6 D plates using a solvent
system consisting o f chloroform-ethanol-water-diethylamine (30:34:8:35 v/v). To
quantify the lipids (32P-labeled phospholipids, or 3H-AA) in each band, the bands were
scraped from the plates and counted in a liquid scintillation spectrometer.
Lipids released from activated cells were also separated into prostaglandin,
peptidoleukotriene, and fatty acid fractions on Amprep C l 8 minicolumns (Amersham)
using the following solvent system: (solvent A); acetonitrile-methanol-water-acetic acid
(8:5:12:0.025 v/v). After washing the column with water, prostaglandin E 2 and related
compounds were eluted with solvent A-water (75:25), peptidoleukotrienes with solvent
A-methanol (50:50), and arachidonic acid with methanol.
Challenge experiments
Eicosanoid release. Differentiated THP-1 cells were labeled overnight with 0.5
|iC/ml 3H-AA (specific activity = 200 Ci/mmole) in RPMI with 10% FBS, then washed
three times with warmed RPMI. Cells were then gently removed from flasks and plated
in 24-well plates at approximately 1.5 x 106 cells/well in 0.5 ml RPMI. Challenge
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concentrations (2x) were added, 0.5 ml/well in RPMI with 4% FBS. Plates were
incubated for 2 hr at 37° C. Supernatants were removed to microfuge tubes and spun at
3000 rpm for 3 min to remove any cells. 200 pi o f the cell-free supernatants were
counted in a Beckman scintillation spectrometer. For uptake experiments, 200 pil o f
supernatants before challenge (counts not taken up), and 200 pi of cell lysates (1 ml 1%
Triton X100) from each sample (uptake) were also counted.
Cytokine release. Differentiated THP-1 cells were plated in 24-well plates at 5 x
105 cells/ml in 1 ml RPMI with 5% FBS. Cells were challenged for 16 hr at 37° C.
Supernatants were collected and stored at -70° C until assayed with ELISA kits for
cytokines released. Amounts released in pg/ml were determined from a standard curve.

Flow Cytometry. After overnight treatment with D3, ceramide (C2), or LPS, THP-1
cells were stained with FITC or phycoerythrin (PE) conjugated monoclonal antibodies to
CD 14 epitopes including anti-CD 14/FITC (M 0-P9) from Becton-Dickinson and antiCD 14/PE (MY-4) from Coulter Labs. PE-conjugated monoclonal antibodies to
constitutively-expressed leukocyte marker, CD45, were used as a positive control stain to
demonstrate consistent staining of samples. The staining period was 30 min at 4°C.
Cells were washed twice with staining buffer (PBS, 0.05% sodium azide, 2% FBS) and
fixed with 1% buffered paraformaldehyde. PE and FITC conjugated isotype-matched
negative control antibodies to myeloma proteins were used throughout to quantitate
nonspecific background binding to target cells. Forward angle (FALS) and 90°
(orthogonal) light scatter gating eliminated debris and dead cells from the analysis on a
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Coulter elite flow cytometer. Data represent the percentage of positively stained cells for
a given antibody, projected beyond the cursors set on negative control histograms to
separate positively and negatively stained cells. Cursors were set so that 1-2% o f all cells
stained with the negative control, isotype-matched reagents were displayed as being in
the positive region o f the histogram.

RESULTS
Grow th, viability, and adherence. THP-1 cells growing between 2 - 6 x 105 cells/ml
in RPMI with 10% FBS show a doubling time o f 72 hours (Fig. 1) and maintain a
viability o f 98% by trypan blue exclusion. Treatment with 0.1 ug/ml LPS R595, 0.1
pg/ml LTA (E. faecalis), or 0.1 |iM vitamin D3 for 24 hours caused temporary or partial
adherence (Fig. 2), though cells could be gently removed from culture flasks by pipeting.
PMA (30 ng/ml) caused significant differentiation within 24 hours to macrophage-like
morphology, including adherence, spreading, and increases in granular inclusions. Nacetylceramide (C2 ceramide), a short-chain, cell-permeable ceramide, did not induce
adherence or morphological changes. Viability remained above 95% with all o f these
treatments except for PMA, which dropped viability to 91% by 72 hours.
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Figure 1. THP-1 Growth Curve. THP-1 cells were maintained at 0.3-lxl06
cells/ml in RPMI with 10% PBS at 37°C in 5% CO 2. Cells were counted by
hemocytometer, and cells/ml were calculated to include dilutions performed when cells
were fed and split every 3 days. Viability was determined to be > 98% by trypan blue
exclusion. A typical experiment is shown.
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Figure 2. Induction of adherence in TH P-l cells by various treatm ents. THP-1 cells
were grown in 24-well plates in 1 ml RPMI with 10% FBS, starting at 5x10 5 cells/ml.
Treatments were added at time 0 when all cells were in suspension. The percent of non
adherent cells was determined every 24 hours by counting non-adherent cells by
hemocytometer, then scraping the wells and counting total cells/ml. Treatments were at
the following concentrations: 0.1 pg/ml LPS (R595), 0.1 pg/ml LTA (E. faecalis), 30
ng/ml PMA, 0.1 pM vitamin D3, and 60 pM C2 ceramide. Viabilities remained above
91% throughout the experiment.
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Lipid composition and distribution o f label in lipid pools. THP-1 cells were
grown for 72 hours in medium containing 0.5 pCi/ml 32P (added as carrier-free H332PC>4).
Under these conditions, the specific activity o f phosphorus (cpm/nmol phosphorus) in
each lipid fraction was identical to the specific activity o f the total cellular phosphorus.
Total lipids were extracted from these cells as described in Materials and Methods, and
the lipids were fractionated by thin-layer chromatography using two solvent systems.
Individual lipids were located by autoradiography and identified by staining and co
chromatography with known standards (Fig. 3). Table 1 summarizes the major
phospholipids in THP-1 cells before and after a 4 hr treatment with LPS (R595 @ 100
ng/ml). The primary phospholipid was phosphatidylcholine (PC) in both cases, but
treatment with LPS resulted in a slight, and transient, decrease in the PC pool.

TABLE 1. Phospholipid composition of THP-1 cells/
Percentage o f Total Lipidb
SM

PC

PI

PE

PA& NL

Control

3

53

13

27

6

LPS

3

49

15

27

6

a) Lipids were separated on Whatman LK6D silica gel plates using a solvent system
consisting o f chloroform-methanol-acetic acid 65:25:8.
b) SM, sphingomyelin; PC, phosphatidylcholine; PI, phosphatidylinositol; PE,
phosphatidylethanolamine; PA, phosphatidic acid; NL, neutral lipids (unidentified).
Experiment was run in quadruplicate, SD<1%.
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Figure 3. Chrom atograph of 32P- phospholipids in THP-1 cells. Lipid extracts of
THP-1 cells grown in medium containing 32P were separated by TLC, as described in
Materials and Methods. Lanes 1-4 are simply varying amounts o f extract spotted on the
plate, from 15|il - 2.5 til. The bands were scraped from the plates and counted for cpm
released. Bands were identified by lipid standards. Values represent the counts for each
lipid as a percent of the total. Experiments run in quadruplicate, SD<1%.
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As discussed in Chapter 1, the release of eicosanoids is an important index of
macrophage activation, and is determined by measuring the amount o f tritium released
from cells labeled with 3H-arachidonic acid. Cells were routinely labeled overnight (18 to
24 hours) prior to challenge. In order to determine the distribution o f label in the lipid
pools, THP-1 cells were treated with 0.1 pM vitamin D3, and labeled with 0.5 [iCi/ml
3H-AA overnight. Samples were removed at intervals, mixed with unlabeled carrier
cells, suspended in cold HBS and centrifuged. The amount o f label taken up by the cells
was determined by counting an aliquot o f the sample before and after removing the cells
by centrifugation. The cells were washed twice with cold HBS, then suspended in 0.3%
NaCl and extracted as described in Materials and Methods. All o f the 3H taken up by
THP-1 cells was incorporated into the lipid pools (Fig. 4A), which suggests that little, if
any, degradation of arachidonic acid prior to incorporation into the lipid pool occurred
under these conditions.

Figure 4B shows that label initially appeared in the PC and

neutral lipid pools. These results suggest that PC is the most metabolically active lipid
and that the label which is initially incorporated into the PC pool is subsequently chased
into the PE pool. This pattern of metabolism is consistent with the hydrolysis of PC to
diglyceride by a PC-specific phospholipase C and the subsequent conversion to both PC
and PE.
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Figure 4. Distribution of tritium in the lipid pools. A) Kinetics o f incorporation o f
label into THP-1 cells over 24 hours. The cells were cultured and extracted as described
in the text and Materials & Methods. Values show the cpm from whole cells and their
total lipid extracts. B) Kinetics of uptake o f 3H-AA into major phospholipid pools.
Values for each lipid show percentages o f the total cpm in the lipid pool, and represent
quadruplicate samples with SD<1%.
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Treatment of THP-1 cells with vitamin D3 did increase the overall uptake o f 3H-AA
slightly. Vitamin D3 treated cells contained 3 x 10s cpm/106 cells (2.1 x 106 cpm/mg
protein) whereas untreated cells contained 2.1 x 105 cpm/106 cells (1.3 x 106 cpm/mg
protein). However, none o f the challenge treatments tested significantly altered overall
uptake o f 3H-AA (Fig.5).
Once incorporated into the lipid pools, 3H-AA can be released by activation o f PLA 2
by various challenges. The arachidonic acid can then be metabolized by specific
enzymes. However, o f the labeled lipid released, the major component was free
arachidonic acid (Fig. 6). To show that, after challenge, most of the arachidonic acid was
released via PLA2 activity as suggested in the literature (27,33), we used PLA2 inhibitor
dexamethasone to block release o f 3H-AA (Fig. 7). It is assumed that the constitutive
release o f 3H in the supernatant is due to turnover by other enzymes or by a PLA2 which
is not affected by dexamethasone.
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Figure 5. Uptake of 3H-AA after treatment. THP-1 cells at 6xl05/ml were pretreated
with 0.1 pM vitamin D3 for 24 hr, and then treated for 3 hr with 100 ng/ml LPS (R595),
50 pM C2 ceramide, 0.25 U/ml Smase (S.aureus), 20 pl/ml aCD45 2D1, or 20 pi IgGi
(isotype matched control). The cells were washed, resuspended in fresh medium, and
labeled with 0.5 pci/ml 3H-AA overnight. Cells were removed by centrifugation, and
200 pi of supernatant were counted. Cell pellets were lysed by freezing in 1 ml 1%
Triton xlOO, and 200 pi of the lysate were counted. Uptake was calculated as a percent
o f the total cpm for each sample. Values are averages o f duplicates ± range.
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Figure 6. Labeled eicosanoids released after challenge. THP-1 cells were pretreated,
and then labeled overnight as in Fig. 4. Cells were washed and resuspended in fresh
medium alone, or with 0.1 pg/ml LPS (R595) or 80 pM C2 ceramide for 3 hr. Cells were
removed by centrifugation, and lipids were extracted from the supernatants as described
in Materials and Methods. Lipids were separated into prostaglandin, peptidoleukotriene,
and fatty acid fractions on Amprep C18 minicolumns. Values similar to those shown
here were seen in > 3 experiments.
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Figure 7. Inhibition of 3H-AA release by dexamethasone. THP-1 cells were
labeled as in Fig. S, washed and resuspended in fresh medium alone, medium plus 20 pM
dexamethasone (Dex), medium plus 100 ng/ml LPS (R595), or medium plus Dex and
LPS. After 3 hr, cells were removed by centrifugation and 200 pi o f supernatants were
counted for cpm released. Values are averages of duplicates ± range.
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CD14 expression. THP-1 cells can be differentiated to a more mature
macrophage-like phenotype with la,25 dihydroxyvitamin D (vitamin D3). We found
that a 24 hour treatment with 0.1 |iM D3 would induce maximal expression o f CD 14,
while leaving the cells only slightly adherent and easy to remove from culture flasks.
THP-1 cells were analyzed by flow cytometry for expression o f CD 14 using two different
monoclonal antibodies: M 0-P9, which does not block LPS stimulation o f THP-1 cells,
and clone MY-4, which does block LPS stimulation (unpublished data, Ribi
ImmunoChem). The histograms in Figure 8 show the increase in expression o f CD 14
M 0 -P 9 following treatment with vitamin D3. Both the percentage of cells staining
positive in the gated population (the histogram peak), and the mean channel fluorescence
(location o f the peak on the X axis) increased by at least 50% for both anti-CD 14
antibodies within 18 hours after treatment with D3. However, neither % positive nor
mean channel fluorescence was significantly altered by LPS, ML A, or ceramide (Table
2 )Consistent with our findings, treatment with vitamin D3 has been reported to
increase sensitivity o f THP-1 cells to LPS (57,69,98), presumably due to the expression
o f CD 14. Figure 9 shows that pretreatment with vitamin D3 also increased THP-1 cell
sensitivity to ceramide for the release of arachidonic acid metabolites. It is unlikely that
expression o f CD14 is involved in ceramide signaling, but it is very possible that D3 upregulates other signal components that have not yet been determined.
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Figure 8. Demonstration by flow cytometry of increased expression of CD14 after
D3 tre a tm e n t THP-1 cells, untreated (top) or treated (bottom) with vitamin D3 for 18
hours, were analyzed for expression o f CD14 using anti-CD14 M0-P9. Cells were
stained and analyzed by flow cytometry as described in Materials and Methods. A)
Gated population, B) anti-CDf4/F!TC, C) anti-CD45/PE (Positive control).
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TABLE 2
Surface expression o f CD 14 measured by flow cytometry after treatment with LPS, C2
ceramide, or vitamin D3.*

TREATM ENT:

Control

LPS

C2

MLA

D3

aCD14(M 0-P9)

5.9b

4.9

5.5

3.9

82.2

8.4C

7.1

7.6

7.2

15.4

aCD14 (MY-4)

aCD45 (2D1)

52.5

67.5

56.7

63.1

97.8

4.4

4.4

4.0

4.0

52.5

98.8

97.8

98.8

98.9

95.7

14.6

15.6

12.5

16.5

9.5

a) THP-1 cells were treated for 18 hr with medium only, 100 ng/ml LPS (R595), 40 pM
C2 ceramide, 100 ng/ml MLA, or 0.1 pM vitamin D3. Cells were then stained and
analyzed by flow cytometry as in Materials and Methods.
b) Percent o f gated (90% vs FALS) cells staining positive
c) Mean channel fluorescence - 4 decade logarithmic range

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

31

co

1400

0>
o
in

1200

in

1000

-

Control
LPS

m m C2

E
Q.

CJ

"O

©
CO
CO
©

&

<
<
CO

0

16

40

64

D3 Pretreatment (hours)
Figure 9. Increased sensitivity o f THP-1 cells after D3 pretreatm ent. THP-1 cells
were treated with 0.1 |iM vitamin D3 for the indicated times, labeled with 3H-AA and
challenged with medium only, 1 ng/ml LPS (R595), or 100 pM C2 ceramide for 4 hr.
200 fjl o f post-challenge supernatants were counted. Values are averages o f duplicate
samples ± range, and results are representative o f 2 experiments.
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DISCUSSION AND CONCLUSION
THP-1 cells have proven to be a good model for our studies as long as they are
cultured at consistently low density (2 - 6 x 10s cells/ml) and maintained for about 20
passages before starting a fresh batch from frozen stocks. Vitamin D3 increased 3H-AA
uptake, CD 14 expression, and sensitivity to challenge, making them responsive for our
assays (Fig 8 & 9, Table 2). Studies have shown that in THP-1 cells, LPS induced
hydrolysis o f phosphatidylcholine (PC), but did not affect lipid pool labeling or the
hydrolysis o f phosphatidylethanolamine (PE) or phosphatidylinositol (PI) (18). We
wanted to confirm this result to provide evidence that our treatments did not affect pool
labeling. Because PC is the major substrate for PLA2, altered pool labeling would
confuse our results. Analysis o f lipid extracts confirmed that the major phospholipids in
THP-1 cells are PC and PE, and that these pools contained the majority o f label following
incubation with 3H-AA (Figs. 3 & 4). Label in the PE and PI fractions remained constant
or increased slightly after 1 0 -1 5 hours o f incubation in the presence o f label, whereas
label in the PC pool dropped off. This suggests that the PC is the most active in terms of
turn-over.
None o f our challenge treatments affected viability, CD 14 expression, or uptake of
3H-AA (Figs 2 & 5, Table 2). Therefore, these parameters could be ruled out as factors
that might have affected sensitivity o f the cells to challenge, and therefore the cpm
released from treated cells.
PMA acts as a diacylglycerol analog, activating cells downstream from receptormediated signaling. It was used as a negative control for experiments assuming a
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receptor-dependent mechanism (Chapter 5). It was not used as a differentiation inducer
due to the high degree o f adherence it caused (Fig.2), the mild cytotoxicity seen, and the
fact that it does not increase CD14 expression (27).
Since free arachidonic acid was the major component of total labeled lipid released
(Fig. 6), changes in the metabolism o f a portion of the free fatty acid to prostaglandins or
leukotrienes might not be apparent from simply measuring 3H-AA release. It was
therefore important for the rest of the studies to check for different patterns of signaling
induced by various challenges, by measuring specific eicosanoids. Inhibition of release
with dexamethasone, a phospholipase A2 inhibitor, showed that most o f the arachidonic
acid released from activated macrophages was due to PLA2 activation (Fig. 7).
Most o f the experiments for this thesis were performed using THP-1 cells.
However, we frequently repeated tests using mouse peritoneal exudate cells (PEC) or
RAW274.6 murine macrophages, and found that the mouse cells responded similarly in
most cases. Experimental data demonstrating this are presented in subsequent chapters.
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CHAPTER 3
ACTIVATION AND DESENSITIZATION OF MACROPHAGES BY
BACTERIAL AMPHIPHILES

Introduction
Septic shock is the pathophysiological response to systemic infections by Gram
negative or Gram positive bacteria. The response includes an exaggerated systemic
inflammatory response, hypotension, intravascular clotting, multiple organ failure, and
death. The biologically active molecules that appear to be involved in the activation o f
this response are amphiphiles located in the outer membrane or wall of these bacteria,
including lipopolysaccharride (LPS) and lipoteichoic acids (LTA), respectively. In Gram
negative septic shock, the majority o f the toxicity is attributed to the lipid A component
o f LPS. LTA is 100 to 1000-fold less potent than LPS, and does not appear to be able to
induce septic shock by itself. There is some evidence that septic shock caused by Gram
positive bacteria results from the combined effects of LTA and peptidoglycan (22).
Nevertheless, LTA has been shown to bind similar receptors as LPS (19,25,38), activate
several common pathways (72), and is able to desensitize cells to subsequent challenge
with LPS (16).
Although structurally different in many ways, both LPS and LTA are anionic
polymers containing lipid, carbohydrate, and phosphorus. Intriguingly, both have also
been shown to vary considerably in potency depending on the source organism
(10,16,38,65), which suggests that minor variations in the molecular structure affect the
34
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ability o f the host to recognize and respond to the amphiphiles. Studies on the molecular
and supra-molecular structure of many forms of LPS have shown that variations in acyl
chain length and fluidity, acylation patterns, saccharide components, and phosphate
residues all affect aggregate formation, and the toxicity and immunostimulatory effects o f
LPS preparations (14,40). Similarly, the charge ratios o f the monomer, the acyl chains,
and the size o f the polyglycerophosphate chain all affect micelle formation o f LTA and
the binding o f LTA to cellular receptors (38). This suggests that immune cells recognize
and respond differentially not only to the molecules themselves, but to these unique
aggregates, so that the signal transduction initiated at the cell surface varies to produce a
wide range o f responses. For example, when LPS from the rough mutant o f Salmonella

minnesota R595 is modified to monophosphoryl lipid A (MLA), toxicity is significantly
reduced but the immunostimulatory activity is maintained (40). A relationship between
structures o f various LTAs and their potencies has not been found. In fact, two similar
LTAs have been shown to have very different potencies in terms of activation of
arachidonic acid metabolism (16).
The potent toxic and immunostimulatory properties o f LPS and other bacterial
amphiphiles result from lipid and protein mediators released primarily from activated
macrophages. It is not clear whether these differential effects result from differences in
the amount o f all mediators released or from a selective increase or reduction of
particular mediators. The phenomenon of desensitization also appears to occur just
downstream from binding and does not appear to involve down-regulation of any LPSbinding surface proteins (28). The ability of LPS preparations to desensitize cells has
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been considered a possible mechanism to exploit in the treatment and/or prevention of
septic shock. Preliminary studies in animal models have shown that pretreatment with
low levels o f LPS, especially the less toxic forms, can be protective (3,40). However, in

vitro studies are necessary to determine the mechanism o f desensitization before the
feasibility o f further in vivo testing would be justified. Because the release o f eicosanoids
is critical in the development of inflammatory reactions, it was important to begin to
characterize the release of arachidonic acid metabolites following treatment with various
bacterial amphiphiles as a baseline for studies on pyrogenicity and the impact o f
monomeric and supramolecular structures on potency and toxicity. The preliminary work
reported here has led to further investigations still underway through a contract with Ribi
ImmunoChem Research.
In this study, we have compared the response o f THP-1 cells to various bacterial
amphiphiles, including LPS RS95 and its derivatives, monophosphoryl lipid A (MLA)
and diphosphoryl lipid A (DPL); smooth LPS from S. abortus, and LTA (E. faecalis) as
measured by the release of arachidonic acid metabolites and pro-inflammatory cytokines.
We also demonstrate the ability of both MLA and LTA to desensitize THP-1 cells to
subsequent challenge with LPS, and this was correlated with the release of a putative
autocrine factor, PGE 2. Experiments repeated using mouse peritoneal cells (PEC) or
RAW264.7 murine macrophages showed similar results.
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MATERIALS AND METHODS
Amphiphiles and reagents. All LPS and lipid A preparations were provided by
Ribi ImmunoChem Research (Hamilton, MT). Stock solutions o f amphiphiles at 1000
|ig/ml were kept at 4° C in 0.1% TEA. Vitamin D3 ( la , 25 dihydroxyvitamin D) was
purchased from Calbiochem (LaJolla CA). LTA from S. faecalis, PMA, and 2mercaptoethanol were obtained from Sigma. Quantikine ELISA kits for tumor necrosis
factor alpha (TNFa), IL-1, and IL-8 were purchased from R&D Systems, and EIA kits
for eicosanoids were from Cayman Chemical (Ann Arbor MI). [3H]-arachidonic acid
was purchased from American Radiolabeled Chemical Co. (St. Louis, MO).
Cell Culture. THP-1 cells from ATCC were cultured in RPMI from Mediatech,
supplemented with 10% Hyclone fetal bovine serum (FBS) and 2 x 10'5 M 2mercaptoethanol at 37° C in a 5% C 0 2 incubator. Cells were maintained between 2.5 x
10s and 1 x 106 cells/ml. Prior to experiments, cells were incubated overnight with a
maturation agent, either 10*7 M vitamin D3 or 2nM PMA. Although loosely adherent,
cells could be removed by pipeting or gentle scraping. RAW 264.7 cells from ATCC
were maintained as adherent monolayers in Dulbecco’s Modified Eagle’s medium
(Sigma) supplemented with 10% FBS. Peritoneal exudate cells were harvested by
peritoneal lavage from Swiss Webster mice as previously described (16). After a 2 hour
adherence period, non-adherent cells were removed by washing with warmed RPMI.
Challenge experiments
Eicosanoid release. RAW 264.7, PEC, or differentiated THP-1 cells were labeled
overnight with 0.5 pC/ml 3H-AA (specific activity = 200 Ci/mmole) in RPMI with 10%
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FBS, then washed three times with warmed RPMI. Cells were then gently removed from
flasks and plated in 24-well plates at approximately 1.5 x 106 cells/well in 0.5 ml RPMI.
Challenge concentrations (2x) were added, 0.5 ml/well in RPMI with 4% FBS. Plates
were incubated for 2 hr at 37° C. Supernatants were transferred to microfuge tubes and
spun at 3000 rpm for 3 min to remove any cells. 200 pi of the cell-free supernatants were
counted in a Beckman scintillation spectrometer. PG and LT fractions were determined
by separation of radiolabeled lipids released from treated cells on Cl 8 minicolumns using
solvent systems discussed in Chapter 2 (Materials and Methods), or by EIA (Cayman
Chemical).
Cytokine release. Differentiated THP-1 cells were plated in 24-well plates at 5 x
10s cells/ml in 1 ml RPMI with 5% FBS. Cells were challenged for 16 hr at 37° C.
Supernatants were collected and stored at -70° C until assayed with ELISA kits for
cytokines released. Amounts released in pg/ml were determined from a standard curve.
Desensitization experiments
Eicosanoid release. Cells were pretreated with MLA or LTA at various
concentrations in medium with 10% FBS for 2 hr prior to the labeling period. Cells were
washed twice with warm medium to remove pretreatment. Labeling and challenge
periods were done as in challenge experiments.
T N F a assay. Cells were pretreated with MLA for 18 hr and were not washed prior to
challenge. Cells were then challenged with LPS R595 at 10 ng/ml for 6 hr. Supernatants
were assayed as in challenge experiments.
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RESULTS
Arachidonic acid release from THP-1 and RAW264.7 cells by bacterial
amphiphiles.

The various challenges showed a range of potencies with respect to their

ability to activate arachidonic acid metabolism in THP-1 cells, with the most dramatic
difference between LPS R595 and MLA (Figs. 1 and 2). THP-1 cells required a
thousand-fold higher concentration o f MLA to release the amount o f eicosanoids released
by LPS R595. A 1000-fold higher concentration of MLA caused only 50% o f the levels
o f cytokines released by LPS R595 (Fig. 3).
Figure 4 shows a significant difference in the potencies o f two MLA preparations,
MPL (MLA solubilized in 1% TEA) and MPL-s (MLA solubilized in 10% ethanol), with
MPL-s approximately 70% more active for release o f arachidonic acid.
In RAW264.7 murine macrophage cells, LPS R595 and E. faecalis LTA showed
similar potencies (Fig. 5).
Prostaglandin/Leukotriene m olar ratios released after challenge.

O f the

eicosanoids assayed, LPS, LTA and MLA all induced primarily prostaglandins, resulting
in relatively high PG/LT ratios compared to amounts released from untreated cells (Fig.
6). In the experiment shown, the ratio of PGE 2/LTC4 from MPL-s is considerably higher
than the other amphiphiles. In other experiments, this ratio tended to slightly higher than
the others, but not as dramatic as shown here.
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Figure 1 and 2. The effect of bacterial amphiphiles on 3H-AA release. Differentiated
THP-1 cells were labeled overnight with O.S jiC/ml 3H-arachidonic acid in RPMI with
10% FBS. Cells were washed and plated in a 24-well plate at l.SxlO6 cells/ml and
challenged with concentrations of LPS R595, MLA, DPL, LPS (S . abortus), and LTA (E
.faecalis) for 2 hours. 200 |il of supernatants were counted for cpm released. Relative
activities were calculated based on labeled metabolites released relative to cells-only
control. Points are averages of duplicates.
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Figure 3. Effect of bacterial amphiphiles on cytokine release. Differentiated THP-1
cells were plated in 24-well plates at lxlO6 cells/ml and challenged with LPS R595 and
MLA in RPMI with 5% FBS for 18 hours. Cytokines released were measured by ELISA
and converted to pg/ml from a standard curve. Values represent amounts released by
MLA as percents o f the amount released by LPS R59S at 10 ng/ml. Points are averages
o f duplicates.
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Figure 4. Difference in potency due to solute: MPL vs MPL-s. Differentiated THP-1
cells were treated as in Fig. 3, and challenged with either MPL or MPL-s for 2 hours.
200 pi o f cell-free supernatants from each sample were counted for cpm released. Values
are averages o f duplicates, ± range.
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Figure 5. Effect of LPS and LTA on arachidonic acid released from RAW264.7
m urine macrophages. RAW264.7 cells were plated in 24-well plates at lxlO6 cells/ml
and allowed to adhere. They were labeled overnight with 3H-AA, and then gently
washed with warm RPMI. The cells were challenged with LPS R595 or LTA (.E
faecalis) for 2 hr. 200 pi of supernatants were counted for cpm released. Values are the
averages o f duplicates ± range.
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Figure 6. PGE2/LTC4 ratios measured from THP-1 cells challenged with LPS,
M LA, DPL, or LTA. Differentiated THP-1 cells were plated in 24-well plates at 5xl05
cells/well in RPMI with 5% FBS, and challenged in 1 mi/well with LPS R595, MLA,
DPL, or LTA (Efaecalis) at 1000 ng/ml. Supernatants were assayed for specific
eicosanoids by El A as per manufacturer’s instructions, and converted to pg/ml from a
standard curve. Molar ratios were calculated for PGE2/LTC4. Values are the averages of
duplicates.
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Desensitization of macrophages by bacterial amphiphiles.

MLA has been

shown to protect mice and humans from the lethal effects o f LPS (3,40). Our data show
that a 18 hr pretreatment with MLA followed by LPS R595 challenge reduced TNFa
release from THP-1 cells by up to 92% (Fig. 7).
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Figure 7. Desensitization by MLA to LPS challenge: T N Fa release. Differentiated
THP-1 cells were pretreated with 100 ng/ml MLA for 18 hours and then challenged with
10 ng/ml LPS R595 for 6 hours. Supernatants were collected stored at -70°C until
assayed by ELISA for TNFa, using Quantikine Kits following manufacturer’s
instructions. The % inhibition was calculated based on the amount of TNF released by
10 ng/ml LPS without pretreatment with MLA.
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A 2-3 hour pretreatment with MLA followed by washing and labeling o f the cells,
reduced eicosanoid release over 50%, even 18 hours after removal o f the MLA (Fig. 8).
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Figure 8. Desensitization by MLA to LPS challenge: 3H-AA release. Differentiated
THP-1 cells were pretreated with MLA at 0, 1, and 10 pg/ml for 2 hours, then washed
and labeled overnight as in Fig. 1. Cells were washed 3x and challenged for 3 hours with
LPS R595 (1 ng/ml). 200 pi of supernatant samples were collected and counted for cpm
released. Values are averages of duplicates.
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Pretreatment for 2-3 hours with LTA also desensitized cells to subsequent
challenge with LPS. This was shown in RAW264.7 cells (Fig. 9), and also in THP-1 and
mouse PECs (data not shown).
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Figure 9. Desensitization of RAW cells by LTA to LPS challenge: 3 H-AA release.
RAW264.7 mouse macrophages were plated at 1>:106 cells/ml in 24-well plates and
allowed to adhere for 2 hr. They were pretreated with LPS (R595) or LTA (E. faecalis)
for 2 hours at concentrations shown, then washed and labeled overnight as in Fig. 1. The
cells were then washed and challenged with LPS R595 at 1 ng/ml for 2 hours. Values
cpm above control and are averages of duplicates. ± range.
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Challenge of THP-1 cells with a vortexed mixture of MPL and LPS R595 at a 10:1
mass ratio resulted in a dramatic attenuation o f the release o f eicosanoids seen with LPS
alone (Fig. 10).
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Figure 10. Effect of LPS/MPL mixed challenge on 3H-AA release. THP-1 cells were
labeled as in Fig. 1 and challenged with LPS R595 and MPL for 2 hr. Mixed challenge
consisted o f dilutions o f MPL and LPS vortexed together in a 10:1 mass ratio
(MPL:LPS). When graphing the mixed challenge, the MPL concentrations were used to
plot points. Values represent the amount of label in 200 til o f supernatant samples
counted for cpm released, and are averages of duplicates, ± range.
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However, if MPL was added 1 hour prior to the addition of LPS (10:1 mass ratio), the
attenuation of LPS potency was not seen (Fig. 11).
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Figure 11. MPL/LPS mixed challenge, adding MPL prior to LPS to allow binding
time. THP-1 cells were challenged as in Fig. 10. However, for one set o f data, the MPL
and LPS were not vortexed together. Instead, the MPL was added 1 hr prior to addition
o f LPS. Again, for mixed challenges, MPL concentrations are shown. Values are
averages of duplicate 200 pi samples of cell-free supernatants, counted for cpm released.
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DISCUSSION
It is widely accepted that the biologically active constituent o f lipopolysaccharide
is lipid A, and it is strongly implicated as the cause of endotoxic shock. However, studies
have shown that the potency o f LPS molecules can be modulated by the configuration o f
the polysaccharide portion (35,65) or the acyl chains (14). Lipoteichoic acids appear to
be at least partially responsible for a similar condition called Gram positive septic shock,
and they also show variations in potency when derived from different Gram positive
organisms (10,16). The purpose o f this study was to quantify lipid mediators released
from macrophages challenged or desensitized with different LPS and LTA preparations.
These data would provide a basis for developing hypotheses regarding the mechanisms
behind the variable potencies, and the desensitization phenomenon. The results reported
here are some of the few comparative studies of eicosanoids released from human THP-1
cells following challenge with bacterial amphiphiles.
The relative potencies of the various amphiphiles were LPS R595 > DPL > S.

abortus LPS and E. faecalis LTA >MLA. It is not clear what events occur at the cell
surface to attenuate the signal transduction events. LPS, LTA (19,45,59), and MLA
(unpublished data) have all been shown to bind the putative receptor, CD 14. CD14 has
been described as a “pattern recognition” receptor (75), meaning that the binding requires
a particular spatial arrangement o f charges. It also has been shown to require monomeric
binding so that aggregates such as micelles are quite inactive (85). With this information,
it is possible to visualize several reasons for the variations in activity o f the amphiphiles
that bind CD14. First, the stability o f the micelle will affect the rate at which conversion
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to monomers occurs. In aqueous solution, less stable aggregates will produce a higher
concentration o f monomers available for binding to CD 14, and these molecules would
most likely show higher potency simply due to availability. Structural variations o f the
fatty acids (length, fluidity), the hydrophilic core cross-sectional area, and the charge
density o f the polar side groups will all affect micelle stability and overall supramolecular
configurations. Lipopolysaccharide binding protein (LBP) has been shown to bind LPS
monomers and facilitate binding to CD 14. This dramatically increases cell
responsiveness to LPS. LTA has also been shown to be much more potent in the
presence o f serum, suggesting that a serum protein may play a similar role for delivery o f
these amphiphiles (16). Therefore, structural features o f the particular amphiphile in the
micelle may also affect the ability o f LBP (or other serum protein) to bind and disperse
the micelle for delivery to CD 14.
Second, slight alterations in the charge pattern of the ligand’s binding site may
strongly affect its affinity for CD 14. This has been shown to be true with the binding o f
various LTAs to the scavenger receptor on macrophages, which is another pattern
recognition receptor (38). Third, there is increasing evidence that CD 14 is more of a
delivery vehicle than a signal transducer, permitting internalization of the ligand via
vesicle formation (97). Activation would then occur after binding to another receptor.
Deacylated, biologically inactive lipid A derivatives have been shown to compete for
binding sites on LBP and CD14, and block LPS responsiveness (56,57). This suggests
that even inactive forms of LPS bind CD 14, but do not transduce the activation signal.
Structural variations would therefore affect binding to subsequent receptors so that
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various amphiphiles might simply be less active due to lower affinity, might serve as an
antagonist, or might activate different pathways resulting in different patterns o f
mediators released.
The data reported here combined with studies o f the supramolecular structure of
various amphiphiles support the micelle stability model o f potency. All o f these
amphiphiles were capable o f desensitizing the cells to subsequent challenge. This
suggests common pathways involved in that regulatory mechanism. Also, all o f the
amphiphiies tested activated similar ratios of PGE 2 /LTC4, suggesting that the same
pathways were activated. In another study with mouse macrophages, smooth and rough
LPS, LTA, and MLA all caused the release of similar PGE2/LTC 4 ratios o f approximately
10:1 (16). Interestingly, Luderitz, et al. (65) showed that lipopolysaccharides o f rough
mutant enterobacteria induced both LTC4 and PGE 2 from mouse peritoneal macrophages,
whereas wildtype (smooth) LPS preparations caused the release of PGE 2 but not LTC4.
The reasons for these different results are unknown.
Correlations between monomer structures and potencies have not been found for
LPS or LTA (10,78). However, Brandenburg, et al. (14) showed that variations in acyl
and saccharide structure combine to produce unique three-dimensional aggregates of the
lipid A derivatives in aqueous environments, and that the ability of the molecules in a
sample to adopt non-lamellar inverted structures is closely correlated with endotoxic
potency (Fig. 12). Inactive forms o f LPS, however, form lamellar structures including
micelles. However, since several different factors affect aggregate formation, it is
unlikely that potency is related to any single monomeric structure. More likely, a set of
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conditions yield a configuration that forms a particular type o f aggregate. It is not known
whether the toxicity is due to the aggregation itself or to the configuration that yields the
aggregate above a certain concentration. It is possible that the critical factor is the
stability o f the aggregate and therefore the availability o f monomers for binding to target
receptors.
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Figure 12. TOP: The relationship between molecular conformation and subsequent
supramolecular structures. From Seydel, et al., 1993(82). Phase behavior,
supramolecular structure, and molecular conformation oflipopolysaccharide.
BOTTOM: The relationship between supramolecular structure and toxicity. From
Brandenburg, et al., 1993(14). Influence of the supramolecular structure of free lipid A
on its biological activity.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

LTA from E. faecalis is o f the Type I structure, consisting o f an unbranched 1,3linked polyglycerophosphate chain linked to a membrane diacyigiyceroglycolipid
containing one (20) or two fatty acid tails (38) (Figure 13). This type lacks compensatory
charges for the heavily negatively charged polyglyceroposphate residues, and includes
some o f the more active LTAs (eg. LTA from E. faecalis, S. aureus) (16). Since the
highly charged outer rim o f the Type I LTA micelle would tend to make the micelle less
stable, this suggests that micellar stability could be a factor in LTA potency as well. The
critical micellar concentration (CMC) for LTA has been reported as 1-10 ng/ml (103) and
28-60 ng/ml (20). Despite this range of reported data, LTA clearly requires relatively
high concentrations o f monomers before micelles begin to form, possibly due to the size
o f the hydrophilic portion of the molecule. Our data show that LTA (E. faecalis)
activates arachidonic acid metabolism well below CMC, as low as 10 ng/ml, and levels
out above 10 ng/ml (unpublished data). This is consistent with the idea that as micelles
form, the concentration of monomers in solution remains constant, in a dynamic
equilibrium with molecules in aggregate form.
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Figure 13. Type 1 Lipoteichoic Acid.
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The micellar stability model is also supported by the fact that two preparations of
MLA, differing only in their solutes, have shown significant differences in potencies for
arachidonic acid release. MLA in 1% TEA (MPL) was much less active than MLA
solubilized in ethanol (MPL-S) (Fig. 14). MPL-S has been shown to have better
solubility than MPL. The MLA used in these experiments was prepared from R595 LPS
and lacks the phosphate group and the 3’ acyl chain on the reducing glucosamine.
o
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Figure 14. Monophosphoryl Lipid A (MLA, MPL)

MLA has been shown to form cubic or lamellar structures due to the lower number of
fatty acids and the reduced charge density o f the glucosamine backbone (82). This type
o f aggregate is correlated with reduced biological activity (14) and might explain some of
the reduced potency o f this lipid A preparation for arachidonic acid release. R595 LPS is
prepared from the deep rough mutant o f Salmonella minnesota R595 in which the LPS
lacks both O side chain and core polysaccharide (Figure IS). R59S has a cone-shaped
monomeric configuration which strongly favors non-lamellar (cubic) supramolecular
aggregates (82). Its relatively high activity is consistent with reported correlations
between non-lamellar structures and toxicity (14,78). The non-lamellar
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Figure 15. ReLPS from S. minnesota.

structures are relatively unstable in aqueous solution due to the exposure o f the
hydrophobic tails to the aqueous solute. The molecules involved may therefore be more
potent due to the ease of transfer from the aggregate to CD 14.
Diphosphoryl lipid A (DPL) is prepared by the removal of the entire inner core and
KDO from R595 LPS (Figure 16). This monomer tends to adopt non-lamellar structures
similar to those o f ReLPS. Our data on DPL activation of arachidonic acid release (Fig.
2) support earlier work showing DPL to be 10-100 fold more lethal and pyrogenic than
MLA in mouse studies (14).

Figure 16. Diphosphoryl Lipid A (DPL).
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The moderate response to LPS from S. abortus (Fig. 2) is interesting since its
structure is o f a smooth LPS, containing complete core polysaccharide and O side chain.
Micelles o f highly glycosylated lipids can vary considerably in stability based on the
lengths o f these sugar residues. The overall trend is toward more lamellar structures with
increasing sugar residues (14). Therefore, our data are consistent with a more lamellar
structure for smooth LPS, and therefore less activity.
When MLA and LPS were added together in a 10:1 ratio to challenge THP-1 cells,
response was significantly reduced compared to challenge with LPS alone (Fig. 10). One
interpretation o f these results is that the MLA competed for binding and blocked
activation of the cells by the more active LPS. Other studies have shown that several
lipid A derivatives compete for binding at LPS binding sites (56,57). However, these
same studies showed that the blockage o f activation occurred at a site distinct from the
binding event (56). If MLA was not actually mixed with the LPS, but was added first and
allowed time to bind to the cells, the attenuating affect was not seen (Fig. 11). It seems
possible that combining MLA with LPS could alter the resulting mixed aggregate from a
non-lamellar aggregate to one that is more lamellar. Another possibility is that lipid A
derivatives block signaling by binding to receptors by the exposed core polysaccharide
while still in an aggregated form, but do not signal due to the unavailability o f the acyl
chains. Rietschel, et al. (79) have shown that the core polysaccharide is critical for
binding, whereas the acyl chains activate signaling. However, we have shown that
prebinding o f MLA followed by LPS challenge did not inhibit the activation by LPS.
This argues against a competitive binding type of inhibition (Fig.9).
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Our results show that THP-1 cells treated with MLA, which has low toxicity,
released significantly lower amounts o f all mediators measured, including labeled
arachidonic acid (Fig. 1), TNFa, II-1, and IL-6 (Fig. 3). The only product shown to
increase following treatment with MLA was prostaglandin, which also increased
following activation with LPS or LTA (Fig. 6). Reduction o f pro-inflammatory
cytokines with concomitant increase in PGE2 may be part o f the reason MLA retains
immunostimulatory properties and the ability to desensitize cells, yet is not endotoxic.
Prostaglandin E 2 has been implicated in autocrine down-regulation of nitric oxide
synthase and tumoricidal activity in mouse macrophages (76), and o f TNF in a human
monocytic cell line (41). It is possible that it is the release of prostaglandin that allows
these agents to desensitize the cells to subsequent challenge.
This limited study on potencies o f bacterial amphiphiles is not conclusive regarding
a predictable model based on monomeric and/or supramolecular structures. However, it
provides some evidence supporting the hypothesis that aggregate stability may play a role
in the variable potencies for the release of arachidonic acid metabolites and proinflammatory cytokines, and therefore in vivo toxicity. These studies also suggest that all
o f these amphiphiles share similar pathways in terms o f the release o f specific
eicosanoids, and in the phenomenon of desensitization.
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CHAPTER 4

A Comparison of the Effects of LPS and Ceramide on Arachidonic Acid
Metabolism in THP-1 Monocytic Cells
Introduction
Recent advances in the study of sphingolipids as mediators o f signal transduction
have provided new clues to the complexities of macrophage activation. In 1989, Okazaki
showed that vitamin D3 treatment ofHL-60 myeloid leukemia cells caused the hydrolysis
o f sphingomyelin, resulting in the release of ceramide with subsequent differentiation of
the cells and growth arrest (73). Since then, many studies have explored the role of
ceramide as a second messenger in different cell types. Ceramide released through the
neutral sphingomyelinase cycle (Figure 1) has been shown to transduce signaling in
immune cells activated with tumor necrosis factor (TNFa) and interleukin 1 (6,54).

OPOCHaCHsN (CHa ^

Sphingomyelin

D A G - ^ Glyewo'
LW' U
pn«pnoiipids

CHOUNE-P
Glyco-

sphingaipids

Ceramide

CH^X

Figure 1. The Sphingomyelinase Cycle. Enzyme I = Sphingomyelinase. Enzyme II
Phosphocholine transferase. (From Ballou, 1996)
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Some o f the biological effects of ceramide in immune cells include cell differentiation,
cell cycle arrest, and in some circumstances, apoptosis. These effects are mimicked by
cell-permeable ceramides such as N-acetylsphingosine (C2 ceramide, Figure 2) (11,54).
There is some evidence that exogenous bacterial sphingomyelinase (SMase) may mimic
ceramide signaling by releasing endogenous ceramide, but a recent study suggests that
the ceramide released is from a distinct pool that is not involved in these signaling
pathways (109).
OH

CE RAMIDE

.CH2OH

C2- CER A M ID E

Figure 2. Ceramide and C2 ceramide, a short-chain, cell permeable analog.

Research has shown that the biological response o f cells activated with LPS is
similar to the response of cells treated with TN Fa or IL-1. However, no accumulation o f
ceramide was observed (52). This, along with the structural similarity between ceramide
and the reducing glucosamine of the lipid A moiety o f LPS, led Wright and coworkers
(52,107) to suggest that LPS may exert its effects through mimicry of ceramide (Fig. 3).
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Figure 3. Structural similarity between ceramide and the acylated reducing
glucosamine of Lipid A. (From Wright, 1995)
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A better understanding o f how LPS exerts its effects on immune cells is
important due to its role as the primary mediator of septic shock. Septic, or endotoxic,
shock is characterized by severe immune dysfunction and can lead to circulatory system
compromise, organ failure, and death (5,13). Most of the toxicity o f LPS has been traced
to the lipid A portion o f the molecule (79), and macrophages appear to be critical players
in the immune dysfunction that leads to systemic failure (30).
Eicosanoids are biologically active arachidonic acid metabolites that are rapidly
released from macrophages following activation with various agents such as LPS and
phorbol myristate acetate (PMA). Free arachidonic acid is released from lipid pools by
the activation of phospholipase A2 (PLA2), and is then metabolized to the various
eicosanoids by specific enzymes. Two o f the major eicosanoids released from
macrophages are prostaglandins (cyclo-oxygenase pathway) and peptidyl-leukotrienes
(lipoxygenase pathway) (31,33,48,105). The ratio of these two lipid families appears to
be important in the regulation o f the immune response (48,100,105). I f LPS mimics the
second messenger function o f ceramide, then exogenous ceramide should cause the
release o f similar combinations o f eicosanoids. LPS increases both PLA 2 and cyclooxygenase activities, but not 5-lipoxygenase in mouse macrophages (33,76,105), and
human monocytes (31). Less is known about the effects of ceramide on arachidonic acid
metabolism. Hayakawa, et al. (46) showed that exogenous ceramide activated
transcription of PLA2 and cyclo-oxygenase 2 in L929 cells. In HL-60 cells, it appears
that the release of arachidonic acid is part of the signal transduction pathways via the
TN Fa and IL-1 receptors that activate the sphingomyelinase cycle (51), and therefore
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occurs prior to the release of endogenous ceramide. There is also some evidence that
TNF may activate two pathways via different lipid pools, one activating PLA 2 and the
other leading to ceramide generation and NF-kB translocation (63,80,104). Clearly, the
signal transduction events that lead to eicosanoid production in response to LPS or the
sphingomyelinase pathway are complex and their interrelationships remain to be
elucidated.
LPS has been shown to desensitize macrophages to subsequent challenge with
LPS (96) so that the release of eicosanoids and cytokines is suppressed. If LPS simply
mimics ceramide, ceramide should show similar effects. Barber, et al. (7) have recently
shown that although exogenous SMase did not desensitize murine peritoneal
macrophages to subsequent challenge with LPS, LPS did desensitize the cells to
challenge with exogenous SMase as measured by the release of TNFa. They suggested
that LPS appears to share some signaling roles with ceramide, but that the signaling
pathways must diverge to produce these results. Their work was done using exogenous
sphingomyelinase from S. aureus under the assumption that it would release endogenous
ceramide in a manner similar to activation of endogenous SMase. However, Zhang, et al.
(109) recently showed that exogenous SMase is unable to mimic the effects of ceramide
generated by endogenous neutral SMase or by cell-permeable ceramides. It will be very
important to determine which treatments most closely mimic endogenous ceramide,
before the mimicry of ceramide by LPS can be elucidated in terms o f signaling pathways.
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In order to address these questions regarding LPS mimicry of ceramide, we
compared the effects of exogenous N-acetylsphingosine (C2 ceramide) and
sphingomyelinase (S. aureus) with those o f LPS on the release o f arachidonic acid
metabolites from THP-1 monocytic cells, and the ability o f these agents to induce a state
o f tolerance to subsequent challenge.

MATERIALS AND METHODS
Materials. THP-1 cells were purchased from American Type Culture Collection
(Rockville MD). Cellgro R P M I1640 was from Mediatech (Herndon VA), and defined
fetal bovine serum (FBS) was purchased from HyClone (Logan UT). Purified LPS R595
from S. minnesota was provided by Ribi Immunochem Research (Hamilton MT).
Tritiated arachidonic acid was purchased from American Radiolabeled Chemical Co. (St.
Louis MO). Vitamin D3 (la , 25 dihydroxyvitamin D) and dihydroceramide were
purchased from Calbiochem (LaJolla CA). Monoclonal antibodies for flow cytometry
were purchased from Becton-Dickinson Immunocytometry Systems (San Jose CA) and
Coulter Laboratories. Enzyme Immunoassay kits were obtained from Cayman Chemical
Co. (Ann Arbor MI). All other chemicals were from Sigma Chemical (St. Louis MO).
Cell Culture. Cells were grown in RPMI supplemented with 10% FBS, 100 U
pennicillin, 0.1 mg/ml streptomycin, and 2 mM L-glutamine, and maintained between 2 6 x 10s cells/ml at 37°C with 5% CO2. Viability remained above 97% throughout the
experiments except where noted. To induce expression of CD 14, the putative LPS
receptor and marker for a more mature (macrophage) phenotype, cells were pretreated for
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24 hours with 0.1 pM vitamin D3. Cells were then labeled with 3H-arachidonic acid
(specific activity = 200 Ci/mmole) at 0.25 pCi/ml overnight.
Cell Activation. Prior to challenge the cells were washed with warm RPMI,
resuspended in 25 ml of RPMI, and transferred to 24-well culture plates (1 ml/well). The
final serum concentration was 2.5%, and final cell densities were between 5 - 8 x 105
cells/ml. N-acetylsphingosine (C2 ceramide) and dihydroceramide were solubilized in
ethanol, and LPS was solubilized in 0.1% triethylamine. Controls were included to rule
out effects of the carriers alone. Endotoxin levels in ceramide and vitamin D3 solutions
were shown to be below detectable levels by Limulus assay kit (Sigma).
At the end of challenge time periods, samples were removed from the wells, cells
were removed by centrifugation, and the supernatant was analyzed for released
eicosanoids. The total tritium-labeled eicosanoids released from cells was determined in
a Beckman scintillation spectrometer (Model LS6500). Individual eicosanoids (PGE 2,
LTC4, and LTB4) were determined by enzyme immunoassay (EIA) analysis per the
manufacturer’s instructions (Cayman Chemical).
Desensitization. Cells were treated with 100 ng/ml LPS (R595), 50 (jM C2
ceramide, or 0.25 U/ml sphingomyelinase (SMase) for 3 hours and then washed and
resuspended in fresh RPMI with 10% FBS prior to the overnight labeling with 3Harachidonic acid (3H-AA).
Flow Cytometry. After overnight treatment with D3, ceramide (C2), or LPS,
THP-1 cells were stained with FITC or phycoerythrin (PE) conjugated monoclonal
antibodies to CD 14 epitopes including anti-CD 14/FITC (M 0-P9) from Becton-
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Dickinson and anti-CD 14/PE (MY-4) from Coulter Labs. PE-conjugated monoclonal
antibodies to constitutively-expressed leukocyte marker, CD45, were used as a positive
control stain to demonstrate consistent staining o f samples. The staining period was 30
min at 4°C. Cells were washed twice with staining buffer (PBS, 0.05% sodium azide, 2%
FBS) and fixed with 1% buffered paraformaldehyde. PE and FITC conjugated isotypematched negative control antibodies to myeloma proteins were used throughout to
quantitate nonspecific background binding to target cells. Forward angle (FALS) and 90°
(orthogonal) light scatter gating eliminated debris and dead cells from the analysis on a
Coulter elite flow cytometer. Data represents the percentage o f positively stained cells
for a given antibody, projected beyond the cursors set on negative control histograms to
separate positively and negatively stained cells. Cursors were set so that 1-2% o f all cells
stained with the negative control, isotype-matched reagents were displayed as being in
the positive region of the histogram.

RESULTS
Sphingomyelinase and C2 ceramide activated arachidonic acid metabolism in
THP-1 cells. Arachidonic acid metabolism in THP-1 cells differentiated with 0.1 pM
vitamin D3, was activated by a wide range of LPS concentrations (0.1 ng/ml - 1000
ng/ml) in medium containing 2.5% FBS (Fig. 4). Activation was seen with C2 ceramide
at concentrations as low as 5 pM (Fig. 4) and sphingomyelinase as low as 0.03 units/ml
(Fig 5).
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Figure 4. LPS and ceramide activate arachidonic acid metabolism in THP - 1 cells.
THP-1 cells were pretreated with vitamin D3 for 24 hr and labeled with 0.5 pC/ml 3HAA overnight. Cells were then washed, resuspended in RPMI with 2.5% FBS, and
challenged with LPS R595 or C2 ceramide for 3 hr. Cells were removed by
centrifugation, and 200 pi of supernatant were counted for cpm released. Values are the
averages o f duplicate samples ± range.
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Figure 5. Activation of arachidonic acid metabolism by exogenous bacterial
sphingomyelinase. Ceils were treated as in Fig. 1 and then challenged with SMase for 3
hr. Cells were removed by centrifugation, and 200 pi of supernatants were counted for
cpm released. Values are averages of duplicates ± range, and represent at least two
experiments.
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Cytotoxicity, as measured by trypan blue uptake, was observed at concentrations o f LPS
above 1000 ng/ml, C2 ceramide above 100 pM, and sphingomyelinase above 1 unit/ml.
Dihydroceramide, due to poor uptake by cells, was used as a negative control, and
elicited little or no response (data not shown).
The response of THP-1 cells to simultaneous challenge with both LPS and ceramide
depended on concentrations of these agents. At lower concentrations o f both LPS and
ceramide, release was slightly higher than with either agent alone (Table 1), but at higher
concentrations o f LPS, the addition of ceramide had little effect.

TABLE I
Concomitant challenge of THP-1 cells with LPS and ceramide*

LPS Concentration (ng/ml)
0

.1

1

10

100

1000

Ceramide
0 pM

0

405(16)b

441(5)

619(6)

1436(88)

1844(61)

40 pM

208(9)

605(11)

691(33)

764(64)

1503(48)

1789(97)

60 pM

359(5)

852(35)

840(5)

987(13)

1446(21)

1664(15)

a) THP-1 cells were treated and labeled as in Fig. 1 and challenged for 2 hr with LPS
(ng/ml) and C2 ceramide (pM) alone and together. 200 pi of post-challenge supernatant
were counted for label released from the cells.
b) Values show cpm released from 1.5 x 10s cells above control values, and are averages
o f duplicate samples + range.
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Prostaglandin E2 /Leukotriene C4 molar ratios were higher from LPS-treated
cells than from ceramide-treated cells. Untreated (control) cells released 40 ±9 pg/ml
o f PGE 2 and 23 ±11 pg/ml o f LTC 4 during the 3 hour incubation period. The ratio of
PGE 2 /LTC 4 in the lipid released from LPS treated cells was about 10 times the value for
untreated cells. In contrast the molar ratio of PGE2 /LTC4 in the lipid released from
ceramide treated cells remained constant (Fig. 6a). This difference resulted from a higher
production of prostaglandin from LPS treated cells (Fig. 6b). Interestingly, the
PGE 2 /LTC 4 ratio increased as the concentration of LPS increased, but remained fairly
constant at all concentrations o f ceramide even though there were increases in both PGE2
and LTC 4 to approximately 100 pg/ml. This suggests that whereas LPS activated cyclooxygenase activity above constitutive levels, ceramide increased PG and LT release only
through increased availability o f arachidonic acid via PLA2 activation, and not through
specific induction of cyclo-oxygenase or lipoxygenase pathways. The amount of PGE 2
from cells treated with SMase was very similar to that o f LPS-treated cells, increasing to
give a PGE 2 LTC4 ratio that was a log higher at maximal SMase concentration than
constitutive levels from untreated cells (Fig. 6c). LTB4 did not significantly increase
following challenge with any o f the activators (data not shown).
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Figure 6 A & B. PG E 2/LTC 4 molar ratios released from THP-1 cells. Supernatant
samples from experiments performed as in Fig. 1 and 2 were assayed for PGE2 and LTC4
by EIA, following procedure provided with the assay kits. A) Ratios in pg/ml were
converted to molar ratios and plotted for cells treated with LPS (top axis) and C2
ceramide (bottom axis). B) Quantities of PGE2 and LTC4 from A expressed as pg/ml.
Values are averages o f duplicate samples.
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Figure 6. (continued) C) PGE 2 and LTC4 in pg/ml from cells treated with SMase.
Values are the averages o f duplicates.
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Desensitization of THP-1 cells. Pre-exposure to LPS induces a tolerant state
during which subsequent challenge with LPS fails to activate several pathways
(27,41,96). In our studies, an initial 2-3 hour treatment of THP-1 cells (or murine
peritoneal macrophages) with 100 ng/ml LPS desensitized them to subsequent challenge
with a wide range o f LPS concentrations so that eicosanoid release remained near control
levels even 20 hours after pretreatment. To determine whether ceamide had the same
effect, we treated THP-1 cells with either LPS (100 ng/ml), ceramide (50 |iM), or SMase
(0.25 U/ml) for 3 hours, then labeled the cells overnight with 3H-AA. Cells were then
challenged with LPS, ceramide, or SMase (Fig. 7). In terms o f 3H-AA release, LPS
desensitized cells to challenge with LPS (Fig. 7A), and partially to challenge with SMase
(Fig. 7C). Pretreatment with SMase desensitized cells to challenge with SMase (Fig. 7C)
and partially to challenge with LPS (Fig. 7A), but primed them for challenge with C2
ceramide (Fig. 7B). Pretreatment with C2 had very little effect on LPS or C2 challenge
(Figs. 7A&B), but primed the cells for SMase challenge (Fig. 7C).
In order to determine whether pretreatment affected the PGE2/LTC 4 ratio in the lipid
released from cells after subsequent challenge, the amounts of PGE2 and LTC 4 were
determined for supernatants o f cells pretreated with either medium alone (control), LPS
(100 ng/ml), C2 ceramide (40 |tM), or Smase (0.25 U/ml), then challenged with 100
ng/ml LPS. Pretreatment with LPS almost completely blocked the increase in PGE2
production following subsequent challenge with LPS. Interestingly, both SMase and C2
ceramide also reduced the amount o f PGE2 produced after LPS challenge, but only to
about half the amount produced from non-pretreated cells (Fig. 8).
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Figure 7. Pre-exposure to LPS, but not ceramide, desensitized THP-1 cells to
subsequent challenge. THP-1 cells were pretreated with D3 as in Fig. 1, then treated
with medium alone (control) (•), 100 ng/ml LPS (o), 0.25 U/ml Smase (A), or 50 piM C2
ceramide (a) for 3 hr. Cells were resuspended in fresh medium and labeled overnight
with 3H-AA. They were then washed and challenged with LPS (A), ceramide (B), or
SMase (C) for 3 hr. Values show relative response of cells after various treatments as the
amount o f label released per 1.5x10s cells divided by the amount of label released from
unchallenged control for each sample, and are averages o f duplicates.
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Figure 8. Pre-exposure to LPS, C2 ceramide, or SMase reduced the PG E 2/LTC 4
m olar ratios released from THP-1 cells challenged with LPS. THP-1 cells were
pretreated as in Fig. 4, and labeled overnight. The cells were then washed and challenged
in RPMI with LPS at concentrations shown. Supernatants were assayed for PGE 2 and
LTC 4 by EIA, following the procedure provided with the assay kits. Ratios in pg/ml
from a standardized curve for averaged duplicate samples were converted to molar ratios.
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DISCUSSION

Recent studies have shown that TNFa, IL ip, and LPS share many biological effects
and activate common kinases and transcription factors such as CAPK, MAP kinase, and
NF-kB (51,104). However, LPS does not activate sphingomyelinase or cause
accumulation o f ceramide (52). Based on these observations, researchers (52,107) have
suggested that LPS may simply mimic ceramide itself. Other observations which appear
to be consistent with this hypothesis include the inability o f cells from LPShyporesponsive C3H-HeJ mice to respond to ceramide (8), the structural similarity
between ceramide and the reducing glucosamine of lipid A (52), and the activation o f a
subset o f LPS-inducible genes by the sphingomyelinase pathway (7).
LPS, C2 ceramide, and SMase all activated arachidonic acid metabolism as measured
by the release of 3H-AA. At low concentrations o f both LPS and ceramide, simultaneous
challenge with both agents enhanced the response o f THP-1 cells and resulted in an
additive to slightly synergistic effect. At higher concentrations o f LPS, however, this
effect was lost, and the amount o f 3H-AA released was reduced below the levels seen
with LPS alone (Table 1). If LPS and ceramide were using separate pathways for
arachidonic acid metabolism, we expected to see an additive effect at all concentrations
since the amounts released through each pathway would be independent o f the other.
However, loss o f this effect at higher concentrations may provide evidence o f a shared
pathway or signaling component that can be saturated.
These results, simply measuring the release o f labeled arachidonic acid metabolites,
are consistent with the mimicry model. However, it is important to look at specific
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eicosanoids released because studies in our lab have shown that free arachidonic acid
accounts for the major portion (approximately 65%) o f the label released from treated
cells (R. Wang thesis, UM, 1997), so that variations in the relative amounts o f the other
metabolites would not be apparent. We were able to show that although both LPS and
ceramide activated 3H-AA release, they induced very different ratios of PGE 2 to LTC 4 .
As shown previously (33,76,105), LPS activated the synthesis o f prostaglandins, but not
leukotrienes, in a concentration-dependent manner. Treatment with SMase also
stimulated PG synthesis and high PGE2/LTC 4 ratios. However, ceramide-treated cells
showed slight increases in both PGE2 and LTC4, maintaining a stable ratio near
constitutive levels. This may simply be due to increased PLA2 activity and available
arachidonic acid, although most of the AA was not metabolized further. These results
suggest that for induction of arachidonic acid metabolism, exogenous SMase more
closely mimics LPS action than C2 ceramide. The reason for this is unclear. However,
exogenous SMase acts at the outer leaflet of the membrane and may release ceramide
from a different pool of sphingomyelin so that it has different signaling properties than
C2 ceramide or ceramide released by endogenous SMase (109).
For several effects of ceramide (as second messenger for TNFa and IL-1 receptors)
and LPS, a common target appears to be ceramide-activated protein kinase (CAPK)
which leads to activation o f MAP kinases and the translocation of activated NF-kB (52).
CAPK may also be involved in the release of eicosanoids. In fact, Schutze (80) has
shown that the TNF receptor has two catalytic domains. One domain activates an acid
sphingomyelinase and leads to NF-kB activation, and another domain activates a neutral
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sphingomyelinase which leads to arachidonic acid release by PLA 2 via CAPK. Jayadev
(51) showed that LPS activated CAPK in HL-60 cells at low concentrations and that it
was mediated by CD 14. Higher concentrations o f LPS are able to activate some
signaling pathways independent of CD 14, which suggests that, like ceramide, there are at
least two mechanisms by which LPS activates signal transduction. It seems possible,
therefore, that LPS may mimic ceramide inasmuch as it can activate a common target,
CAPK, but that some o f its activities occur without this shared mediator (Fig. 9).
Additional support for a model in which LPS and ceramide use separate pathways
for arachidonic acid metabolism comes from our desensitization studies. Pretreatment of
THP-1 cells with LPS desensitizes cells to subsequent challenge with LPS even up to
1000 ng/ml. However, pre-treatment with LPS did not affect the release o f label after
challenge with C2 ceramide. Pretreatment with C2 ceramide had little effect on LPS
challenge, but primed them for release following SMase challenge. Like desensitization,
priming o f immune cells for subsequent challenges is an important part of the regulation
o f the immune response (26,74), and results in a much higher release of mediators than
that seen without the pretreatment. Because the response o f THP-1 cells to LPS differs
so dramatically from their response to ceramide treatment, our results suggest that LPS
and ceramide do not share a single regulatory pathway. It is possible that LPS may use
another membrane target containing a regulatory mechanism that is independent o f the
CAPK pathway. It is also possible that these results are due instead to an autocrine effect
by the high levels of prostaglandins released by LPS-treated cells. PGE2 has been
implicated in the autocrine down-regulation of nitric oxide synthase and tumoricidal
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Figure 9. A hypothetical scheme of signaling pathways for arachidonic acid
metabolism activated by LPS or ceramide, and the putative shared pathway of
ceramide mimicry by LPS. Compiled from various works, as sited in the text.
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activity in mouse macrophages (76), and o f TNF in a human monocytic cell line (41). If
a high PGE2/LTC4 ratio is required for desensitization, it may explain why LPS, but not
ceramide, is able to desensitize cells to subsequent challenge. It is interesting that
SMase, which also caused the release of high PG/LT ratios, was also able to partially
desensitize cells to subsequent challenge.
Our data strongly suggest that there are significant differences in the signaling
pathways for LPS and ceramide in terms of specific eicosanoids released and in terms of
regulation by desensitization. Because o f the critical role prostaglandins and leukotrienes
play in modulating the immune response, these differences are particularly important.
Perhaps even more interesting is our evidence that C2 ceramide and exogenous
sphingomyelinase had very different effects. Continuing studies are needed of the
specific pools o f sphingomyelin from which ceramide is released endogenously by
various agents. This will then allow us to explore the possibility of separate pools of
arachidonic acid subsequently released as the substrate for cyclo-oxygenase, located in
the endoplasmic reticulum, and soluble 5-lipoxygenase. There is evidence that this kind
o f compartmentalization allows for the production o f prostaglandins, but not leukotrienes,
by LPS (50).
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CHAPTERS
MONOCLONAL ANTIBODIES TO CD45 MODIFY LPS-INDUCED
ARACHIDONIC ACID METABOLISM IN MACROPHAGES

Introduction
Considerable evidence has accumulated that macrophage activation by LPS occurs via
a receptor complex consisting of a receptor (CD 14) and associated tyrosine kinases o f the
src family (32,43,60,98). Signaling through CD 14 has several similarities to the signaling
through the T cell and B cell receptors. These include 1) a requirement for a means to
transmit the message into the cell due to the lack of a cytosolic tail on the receptor, 2)
activation of protein tyrosine kinases of the src family, and 3) proliferation o f multiple
signals. The initial dramatic increase in tyrosine phosphorylation is transient (99), which
suggests that a regulatory mechanism removes the phosphate groups. It seems likely that
this would be a protein tyrosine phosphatase (PTPase) activity.
CD45, the Leukocyte Common Antigen, is a transmembrane protein tyrosine
phosphatase (PTPase) that plays a major role in signal transduction in T cells, B cells,
natural killer cells, and neutrophils (44,58,61,62,87). It is the most abundant and well
characterized of the family of transmembrane protein tyrosine phosphatases in
hematopoietic cells (2,58). The molecule (Fig. 1) consists of three domains: a large,
extensively-glycosylated extracellular N-terminal domain, a single transmembrane domain,
and a cytosolic C-terminal domain that contains two protein tyrosine phosphatase
activities (86,89). One of these activities appears to be an autoregulatory protein tyrosine
82
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phosphatase (102). Alternative splicing of three variable exons encoding portions o f the
extracellular domain leads to expression of several isoforms o f CD45. These range in
molecular weight from 180 - 240 kD, and their expression is tightly regulated during
development and activation o f lymphocytes (93).

30 -1 8 0 aa N-Terminal Domain
'(O-linked glycosylation, isoform
specific)
390*550 aa
Extracellular Domain

360 aa Cysteine-Rich Domain
(N-linked glycosylation)

Cell Membrane

- 22 aa Transmembrane domain

_ 240 aa Catalytic Domain 1
(PTPase)

700 aa
Cytoplasmic Domain
-

240 aa Catalytic Domain 2
(PTPase)

COOH
Figure 1. CD45 protein tyrosine phosphatase (Leukocyte Common Antigen)

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

Although found on monocytes and macrophages (39,61,64,77), CD4S has
primarily been studied in lymphocytes. Such studies have demonstrated that CD4S is part
o f the receptor complexes on T and B cells, in which its major substrates for
dephosphorylation appear to be protein tyrosine kinases (PTK) (2,15,87). This suggests
that CD45 has a regulatory role in proximal signal transduction by modulating the
phosphorylation - dephosphorylation equilibrium, thereby coupling specific surface
receptors to downstream tyrosine kinase-dependent signaling. CD45 is involved in both
positive and negative regulation depending on whether the particular kinase substrate has
phosphorylated tyrosines at inhibitory sites or activation sites (93).
Studies regarding the roles of CD4S in monocytes and macrophages are much
more limited. CD4S expression has recently been shown to be up-regulated on activated
epithelium-lining macrophages (94), and C5a-activated monocytes (23). There is some
evidence for CD45 involvement in monocyte adherence (64), in synergizing with LPS in
triggering M-CSF production (39) and respiratory burst in monocytes (61), and in
regulation o f Fey receptor-induced calcium mobilization (53,77). Thus, it is clear that
CD45 may be involved in several aspects o f macrophage activation. However, very little
is known about the role of CD45 in the activation o f macrophages by LPS. Since
activation by LPS via CD 14 results in tyrosine phosphorylation (60), this pathway is most
likely regulated by a protein tyrosine phosphatase. Although tyrosine phosphorylation has
been associated with eicosanoid biosynthesis in macrophages (33), there have been no
studies linking CD45 to the regulation o f arachidonic acid (AA) metabolism, another
important result of macrophage activation. B cells have been shown to be able to respond
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to LPS independent of CD45 (55), but it is possible that this is via a CD 14-independent
pathway such as polyclonal linkage of surface IgM.
The major objective o f this study was to determine whether or not the CD45
protein tyrosine phosphatase plays a role in the activation and desensitization of
arachidonic acid metabolism by LPS in THP-1 cells. The hypothesis was based on the role
o f CD45 in T cells and the apparent similarity between that signaling system and the one
used by LPS via CD 14, including the evidence of a receptor complex, activation of
tyrosine kinases, and the transient nature o f the tyrosine phosphorylation induced by ligand
binding. Anti-CD45 monoclonal antibodies (mAb) to CD45 were used to explore
expression o f CD45 on THP-1 cells, to measure their effect on activation and
desensitization o f AA metabolism by binding or cross-linking surface CD45, and to
correlate these effects with signaling through the CD 14 pathway.
MATERIALS AND METHODS
Materials: THP-1 cells were purchased from American Type Culture Collection
(Rockville MD). Balb/C and Swiss Webster mice were obtained from Jackson
Laboratories. Cellgro RPMI 1640 was from Mediatech (Herndon VA), and defined fetal
bovine serum (FBS) was purchased from HyClone (Logan UT). Purified LPS R595 from

S. minnesota, monophosphoryl lipid A (MLA), and diphosphoryl lipid A (DPL) were
provided by Ribi Immunochem Research (Hamilton MT). Tritiated arachidonic acid was
purchased from American Radiolabeled Chemical Co. (St. Louis MO). Vitamin D3 (la ,
25-dihydroxyvitamin D) was purchased from Calbiochem (LaJolla CA). Anti-CD45, antiCD45RA, anti-CD45RO, and M 0-P9 anti-CD 14/FITC monoclonal antibodies and
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isotype-matched negative controls were from Becton-Dickinson Immunocytometry
Systems. Anti-mouse anti-CD45 monoclonal antibodies (HI-30) were from Pharmingen
(San Diego CA). Enzyme Immunoassay Kits were obtained from Cayman Chemical Co.
(Ann Arbor MI). Anti-CD45 (BRAS 5 biotin-conjugated), anti-CD 14 (UCHM-1 biotin
conjugated), isotype matched controls, anti-phosphotyrosine (biotin-conjugated), avidin,
and all other chemicals were purchased from Sigma Chemical Co. (St. Louis MO).
Cell Culture. Murine peritoneal macrophages were harvested from mice by
peritoneal lavage using 10 ml RPMI with 10 pg/ml gentimicai injected into the peritoneal
cavity. Cells were plated to 24-well plates and, after a two hour adherence period, non
adherent cells were washed off, and fresh medium was added. THP-1 cells were grown in
RPMI supplemented with 10% FBS, 100 U penicillin, 0.1 mg/ml streptomycin, and 2 mM
L-glutamine, and maintained between 2 - 6 x 10s cells/ml at 37° C with 5% CO2 . Viability
remained above 97% (by trypan blue exclusion) throughout the experiments except where
noted. THP-1 cells were pretreated for 24 hours with 0.1 pM vitamin D3 to induce
expression o f CD 14, the putative LPS receptor and marker for a more mature
(macrophage) phenotype. They were then labeled with 3H-arachidonic acid at 0.25 |iCi/ml
overnight.
Cell Activation. Prior to challenge the cells were washed with warm RPMI,
resuspended in 25 ml of RPMI, and transferred to 24 well culture plates (1 ml/well). The
final heat-inactivated serum concentration was 2.5 - 5%, and final cell densities were
between 5 - 8 x 10s cells/ml. LPS was solubilized in 0.1% triethylamine in a 100 mg/ml
stock solution. Monoclonal antibodies were titered for use at approximately 2 (ig/ml for
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106 cells, and diluted in RPMI. Controls were included to rule out effects o f the carriers
alone. Isotype-matched anti-myeloma protein mAb were used to rule out effects of
binding by FcR on the macrophages. Endotoxin levels of vitamin D3 and media solutions
were shown to be below detectable levels by Limulus assay.
At the end of challenge time periods, samples were removed from the wells, cells
were pelleted by centrifugation, and 200 jjJ o f the supernatant were counted in a
Beckman scintillation counter to determine the amount of radiolabeled arachidonic acid
metabolites released. Supernatants were also assayed for specific eicosanoids
(prostaglandin E2, leukotriene B4, and leukotriene Gt) using EIA kits, following
manufacturer’s instructions (Cayman).
Desensitization. Cells were treated with 100 ng/ml LPS (R595), with or without
anti-CD45, for 3 hours and then washed and resuspended in fresh RPMI with 10% heatinactivated FBS prior to the overnight labeling with 3H-arachidonic acid (3H-AA).
Cross-linking of surface receptors. Cross-linking of CD4S and CD 14 was
accomplished in two ways. First, cells were treated with Anti-CD45 2D1 for 10 min at 1
|ig/ml, then washed and plated to wells in 24-well plates at 5x10s cell/ml. Anti-mouse IgG
was added at 1 |ig/ml to cross link the bound mAb prior to challenge. Second, cells were
treated as above with biotinylated anti-CD45. Cells were then washed to remove free
mAb. Avidin was then added at 30 pl/ml prior to challenge.
Flow cytometry. After overnight treatment with LPS R595, MPL, or C2
ceramide, D3 pretreated THP-1 cells were stained with FITC or phycoerythrin (PE)
conjugated monoclonal antibodies to CD45, CD45RA, and CD45RO from Becton-
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Dickinson. The staining period was 30 min. at 4° C. Cells were washed twice with
staining buffer (PBS, 0.05% sodium azide, 2% FBS) and fixed with 1% buffered
paraformaldehyde. PE and FITC conjugated isotype-matched negative control myeloma
proteins were used throughout to quantitate nonspecific background binding to target
cells. Forward angle (FALS) and 90° (orthogonal) light scatter gating eliminated debris
and dead cells from the analysis on a Coulter Elite flow cytometer. Data represent the
percentage o f positively stained cells for a given antibody, projected beyond the cursors
set on negative control histograms to separate positively and negatively stained cells.
Cursors were set so that 1-2% o f all cells stained with the negative control, isotypematched reagents were displayed as being in the positive region of the histogram.
SDS-PAGE and W estern Blotting. D3-pretreated THP-1 cells (1 x 107) were
lysed in 1 ml lysis buffer for 1 hr at 4° C. (Lysis buffer = 1% Triton X100, 20mM Tris
HC1 (pH 7.4), 137 mM NaCl, 2mM EDTA, ImM phenylmethylsulfonylfluoride (PMSF), 1
pg/ml each o f pepstatin, aprotinin and leupeptin, 1 mM sodium orthovanadate (NaVO-t),
and 100 pM phenylarsine oxide (PhAsO).) The lysate was pelleted at 10,000 g for 30
min, and supernatants were transferred to fresh tubes. For immunoprecipitation, 20 pi of
anti-CD45 was added and incubated for 2 hours at 4° C. 50 jj.1 o f protein-G sepharose
was then added and incubated at 4° overnight on an inverter shaker. Precipitate was
washed twice in lysis buffer, and once in wash buffer (50 mM Tris HCI 7.4, 200 pM
NaVC>4, 100

PhAsO). Samples were boiled for 5 min prior to loading onto 7.5%

SDS-PAGE gels. Gels were run in a BioRad Minigel apparatus for 40 - 60 min, then
blotted onto PDVF membranes. Blots were stained with primary antibodies or with
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biotinylated Abs for 2 hours at room temperature in blocking buffer, then washed for 30
min. If needed, biotinylated 2° antibody was used to stain the primary Ab, and the
membrane was washed again. Blots were stained for 1 hour at room temperature in
blocking buffer with streptavidin:horseradish peroxidase, then washed 15 min with 60°
wash buffer, and subsequent washes at 37° for 15 min and 5 min. Blots were developed
and films exposed using enhanced chemiluminescence (ECL) kits from Amersham.

RESULTS
TUP-1 cells express CD45 constitutively. Figure 2 shows flow cytometry
histograms from cells stained with three different monoclonal antibodies (mAb) specific
for three o f the CD45 isoforms commonly expressed on leukocytes. Each histogram has a
peak representing the percent of cells in the gated population that stained positively with
the indicated antibody. The position of the peak on the X axis shows mean channel
fluorescence, a measure of how brightly the cells are stained. The first two histograms
show staining with negative control, (IgGi/IgGa) conjugates, phycoerythrin (A) and FITC
(B). The cursors are set on these controls so that only a small percentage (0 .1 -1 .6 % ) of
the cells staining with the negative controls are counted as positive. Histogram C shows
that 24.5% o f the gated cells stained with anti-CD45RO/PE with a mean fluorescence o f
3.52. Generally, CD45RO is the isoform expressed on activated T cells, and CD45RA is
more often expressed on quiescent cells. Histogram D shows 63.1% of the cells stained
positive with anti-CD45RA/FITC with a mean fluorescence of 0.628. This means that
although more cells expressed CD45RA, there were significantly fewer molecules
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expressed/cell than CD45RO. Histogram £ shows 95.7% of the cells stained positive for
anti-CD45, a mAb that recognizes all known isoforms of CD45, at a mean fluorescence o f
9.52.
This pattern did not change significantly following treatment with LPS, MPL, or
ceramide (Table 1), suggesting that activation of macrophages by these agents does not
alter expression o f CD45 isoforms. There was a 50% reduction in % positive cells stained
for isoforms RO and RA after treatment with C2 ceramide. Little is known about the
regulation o f CD45 isoforms on macrophages, and I did not explore this using THP-1 cells
since it would have required comparing expression on these cells with several other cell
systems. The alteration in expression following C2 treatment was intriguing, however,
and would make another interesting study.
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Figure 2. CD45 expression on THP-1 cells. D3-pretreated THP-1 cells were stained
for flow cytometry as described in Materials and Methods. A)IgGi/IgG2a isotype matched
control conjugated with phycoerythrin; B) IgGi/lgCha isotype control conjugated with
FITC; C) Anti-CD45RO/PE; D) anti-CD45RA/FITC; E) anti-CD45/PE.
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TABLE 1
Surface expression of CD45 isoforms on vitamin D3-pretreated THP-1 cells
following treatment with medium, LPS, C2 ceramide, or MPL, as measured by flow
cytometry.'

TREATMENT:

Control

aCD45RA

LPS

MPL

Ceramide

61.4
0.6

53.9
0.557

35.7
0.428

a CD45RO

24.5
3.52

27.4
3.43

25.2
3.64

12.5
3.3

aCD45 (pan)

95.7
9.52

97.1
14.2

97.8
11.2

97.7
11.3

a) THP-1 cells were treated for 18 hr with medium only (control), 100 ng/ml LPS R595,
1000 ng/ml MPL, or 40 pM C2 ceramide. Cells were then stained and analyzed by flow
cytometry as described in Materials and Methods.
b) Percent o f gated (90° vs FALS) cells staining positive
c) Mean channel fluorescence - 4 decade logarithmic range

When whole cell lysates were separated by PAGE and Western blotted, anti-CD45
clone BRA55 (Sigma) stained a set o f three bands at 240, 200, and 180 kD (Fig. 3a). This
suggests that the full range of isoforms sizes are expressed on THP-1 cells, all of which
contain the epitope bound by BRA55. Anti-CD45 2D1 (Becton-Dickinson) stained a
single band at 220 kD (Fig. 3b).
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Ponceau
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Ponceau
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CD45 from untreated THP-1 cells
stained with anti-CD45 BRA55

CD45 from untreated THP-1 cells
stained with anti-CD45 2D1

Figure 3. Western blot of CD45 on THP-1 cells. Whole cell lysates o f D3-pretreated
THP-1 cells in sample buffer were loaded onto 7.5% SDS-PAGE gels and run in a
min-gel apparatus for 40 min. Proteins were then blotted onto PDVF membranes.
Blots were stained with either biotinylated anti-CD45 BR.A55 (a), or anti-CD45 2D1
followed by 2° biotinylated anti-mouse anti-IgG (b), and then streptavidin:HP. Blots
were developed and films exposed using ECL.

Anti-CD45 mAb increased the release of labeled arachidonic acid metabolites
and TNF from LPS-challenged cells. Addition of anti-CD45 2D1 just prior to
challenge with LPS increased the release of Aa slightly (Fig. 4a), but when added 18 hr
prior to challenge there was a 2-fold increase over the amount released from cells
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challenged only with LPS (Fig. 4b).
Similar results were seen when mouse peritoneal cells (PECs) were treated with
anti-mouse aCD45 18 hours prior to challenge (Fig. 5). Like the increase seen with THP1 cells, aCD45 resulted in at least a doubling o f the amount o f 3H-AA released.
Macrophages express Fc receptors (FcR) for binding particles opsonized with
antibodies. Binding o f FcR can lead to activation o f several pathways (21,77). To
determine whether FcR activation was a factor in the increased arachidonic acid release,
THP-1 cells were treated with isotype matched control antibodies for 2 hours. Figure 6a
shows that although LPS and anti-CD 14 UCHM-1 activated AA release, anti-CD45 2D1
had only a slight effect by itself. IgGi (isotype control for 2D1) and IgG^ (isotype control
for UCHM-1) had no effect. Fig. 6b shows that the isotype matched negative control
IgGi did not have any effect on LPS challenge.
Anti-CD4S 2D1 affected a signaling pathway activated by LPS other than
arachidonic acid metabolism, that leading to TN Fa production. It had no effect alone on
TNF production, but synergized with LPS to release 33-42% more TNF from cells treated
with 1-10 ng/ml of LPS, respectively (Fig. 7).
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Figure 4. Anti-CD45 mAb increased 3H-AA release from LPS-challenged THP-1
cells. D3-pretreated THP-1 cells were labeled overnight with 0.5 |j.C/mI 3H-AA, then
washed and resuspended in RPMI for plating in 24-well plates at 1.5xl06 cells/well.
aCD45 2D1 was added either immediately prior to challenge (a), or 18 hours prior to
challenge (b). The cells were challenged with LPS R595 at concentrations shown for 3 hr.
Supernatants were centrifuged to remove cells, and 200 jJ o f supernatants were counted
for cpm released. Values represent cpm released from 3x10s cells above control values
for cells challenged with medium alone, and are averages o f duplicates ± range.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited without p erm ission.

96

tn

5000
LPS
LPS & anti-C D 45

®
o
in
®
X

4000

*-

E

a
o . 3000 a
hi

CO

2

2000

IAJ

a:
3

1000

-

z

CO

0.1

1.0

10

100

1000

LPS CONCENTRATION (ng/ml)

Figure 5. Anti-CD45 increased 3H-AA release from LPS-challenged mouse
peritoneal exudate cells (PECs). PECs were harvested from 6-week old Balb/C mice
and plated in 24-well plates. After a 2 hr adherence period, non-adherent cells were
removed by washing, and adherent cells were labeled overnight as before, one plate
containing anti-mouse aCD45, 1 pg/ml) and one plate with no mAb. Wells were washed
and cells were challenged with LPS R595 for 2 hr. Values represent cpm released above
control values for unchallenged cells, and are averages of duplicates ± range.
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Figure 6 . Isotype-matched control antibodies had no effect on AA release. D3pretreated THP-1 cells were labeled overnight as before, then washed and plated at 5x10
cells/well. LPS (1 pg/ml) or 1 pg/ml of the various antibodies were added to wells. The
mAbs used were aCD45 2D1 (Becton-Dickinson, IgGi), IgGi isotype control (BectonDickinson), aC D 14 UCHM-1 (Sigma, IgG^), and IgG^ isotype control (Sigma). Cells
were challenged for 2 hr, then 200 jil of supernatants were counted for cpm released.
Values are averages of duplicates ± range.
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Figure 7. Anti-CD45 increased release of TNFa from THP-1 cells challenged with
LPS. Vitamin D3-pretreated THP-1 cells were challenged for 20 hr with LPS R595 at
concentrations shown, with or without 1 (ig/ml aCD45 2D1. Supernatants were assayed
for TNFa released by ELISA according to manufacturer’s instructions. TNFa in pg/ml
was calculated from a standard curve.
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Cross-linking of CD45 inhibited LPS-induced activation of AA release.
CD45 was cross-linked on THP-1 cells using two methods. Anti-CD45 was allowed to
bind to cells for 10 minutes prior to the addition of either avidin (to cross-link biotinylated
anti-CD45), or anti-mouse IgG (to cross-link the Fc domains o f the bound anti-CD45).
Figure 8 shows that both methods reduced AA release significantly from that released
from LPS-challenged cells. IgGi isotype control and the anti-mouse IgG mAb had no
effect.

<xCD45
C ro ss-lin k ed w ith avidin
C ross-linked
with algG

—W 1800
S

me

1600

1a.

ain

mmm

(0

mm
UJ

oc

5S35SK553

*

mm

nX

Medium lgG1 algG
100 ng/ml LPS

Figure 8 . Cross-linking CD45. D3-pretreated THP-1 cells were labeled overnight with
3H -A A , then divided into flasks containing either medium alone o f 1 pg/ml o f anti-CD45
BRA55. After 10 min to allow binding, cells were washed and resuspended in fresh
medium, and plated at 5x10s cells/well. Either anti-mouse algG (1 ng/ml) or 20 pi avidin
were added to cross-link via Fc domains or biotinylated aCD45, respectively. Cells were
then challenged with LPS R595 for 2 hr. 200 pi of cell-free supernatants were counted
for cpm released. Values represent relative response, calculated by dividing cpm released
from challenged cells by the cpm released from unchallenged cells, and are averages of
duplicates.
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Desensitization and anti-CD45. As shown in previous chapters, LPS
pretreatment dramatically reduces eicosanoid release following subsequent challenge.
Figure 9 shows that anti-CD45 added during the desensitization period (2-3 hours) did not
affect the ability o f LPS to desensitize the cells. However, addition o f anti-CD45 during
that period without LPS resulted in increased release after subsequent challenge.
Therefore, treatment of these cells with anti-CD45 18-20 hours prior to challenge
increased release o f AA even if the unbound antibodies are washed away after 2 hours,
although to a lesser extent than if the mAb were left in overnight.
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Figure 9. Pretreatm ent with aCD45 had no effect on desensitization by LPS. D3pretreated THP-1 cells were treated with medium alone, 100 ng/ml LPS R595, 1 pg/ml
aCD45 2D1, or LPS and aCD45 together for 3 hr. The cells were then washed and
labeled overnight as before. They were washed and plated at lx l0 6/well, and challenged
with LPS at 1 pg/ml for 2 hr. 200 ^1 of cell-free supernatants were counted for cpm
released above controls, and values are averages of duplicates.
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Production of prostaglandin E2 . One of the important eicosanoids released from
LPS-activated macrophages is PGE 2 (see Chapter 4). Figure 10 shows that anti-CD45
increased production of PGE 2 from LPS-challenged cells. There was no production o f
LTC 4 or LTB4 with either LPS, LPS and anti-CD45, or anti-CD45 alone (data not
shown). This suggests that, in terms o f prostaglandin and leukotriene production, antiCD45 simply increased the signal generated by LPS, but did not change which signaling
pathways were activated. This is further evidence that the effect seen with anti-CD45 is
not due to FcR binding, since activation o f signaling by FcRy has been shown to cause the
production of LTB4 from both monocytes and PMNs (49,83).
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Figure 10. aCD45 increased PGE2 released from LPS-challenged cells. Samples
from Fig. 3 were assayed for PGE 2 using EIA, following manufacturer’s instructions.
PGE 2 in pg/ml was calculated from a standard curve. Values are pg/ml released above
control, and are averages of duplicates.
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Correlation o f the effects of anti-CD45 with signaling through the CD14
signaling pathway. Because LPS activates tyrosine phosphorylation via CD 14 (33), this
pathway is likely to have an associated protein tyrosine phosphatase. This series of
experiments was done under conditions that emphasized signaling through CD 14. CD 14
specifically binds complexes of LPS and its serum binding protein, LBP. Therefore, THP1 cells were challenged in medium without serum to determine the effect of anti-CD45 in
the absence of LBP. Rather than the dramatic increase seen in medium containing 5%
serum (Fig. 4), a slight reduction in release was seen with anti-CD45 in the absence of
serum (Fig. 11).

tt

1400

01
o
in
1200
O

ia

1000

LPS

-

L P S & anti-C D 45
-

o
o
UJ

CO

<

600

Ul

400

UJ

tc

<
*

200

•

0

0.1

1.0

10

100

1000

LPS CONCENTRATION (ng/ml)
Figure II. Lack of serum in the challenge prevented the increase in AA release by
aCD45. D3-pretreated THP-1 cells were labeled and challenged as in Fig. 3 except that
no serum was added to challenge medium. Values represent cpm released in 200 pj of
cell-free supernatants, and are averages of duplicates ± range.
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Pretreatment o f THP-1 cells with vitamin D3 increases CD 14 expression 50-80%
(Chapter 2, Table 1). Therefore, effects o f aCD45 were compared on cells treated with

D3 to cells that were not pretreated with D3. Without D3 pretreatment, aCD45 had very
little effect except at the highest LPS concentration (100 ng/ml) (Fig. 12). The effect was
seen with cells treated with D3 even at the lowest concentration of LPS tested (0.1 ng/ml).
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Figure 12. Pretreatm ent w ith vitamin D3 increased the effect of aC D 45 on AA
release. Equal volumes o f THP-1 cells at 5x105 cells/ml, either treated or not treated with
vitamin D3 (0.1 pM), were labeled and challenged as in Fig. 3. Values represent cpm
released in 200 pi of cell-free supernatants above control, and are averages o f duplicates ±
range.
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Several other bacterial amphiphiles have been shown to bind CD 14, including MPL,
DPL, and LTA (See Chapter 3). Other agents, including C2 ceramide, sphingomyelinase
(SMase), and phorbol myristate acetate (PMA), activate AA metabolism independent of
CD 14 binding. Anti-CD45 increased release from cells treated with all o f the CD 14
ligands (Figure 13), but none of the CD 14-independent agents (Figure 14).
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Figure 13. aCD45 affects AA release activated by other CD14 ligands: MPL-s,
DPL, and LTA. D3-pretreated THP-1 cells were labeled as in Fig. 3, and challenged
with medium alone, or 1 pg/ml LPS R595, MPL-s, DPL, or LTA (E. faecalis) for 2 hr.
Values represent cpm released in 200 pi o f cell-free supernatants above control, and are
averages o f duplicates ± range. The experiment was repeated 3 times.
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Figure 14. aCD45 did not affect 3H-AA release activated by agents using CD14independent signaling. D3 pretreated THP-1 cells were labeled as in Fig. 3 and
challenged with 50 jjM C2 ceramide, 0.5 U/ml SMase, 10 ng/ml LPS for 2 hr, or 20 ng/ml
TNF, 30 ng/ml PMA for 5 hr. Values represent cpm released in 200 |il cell-free
supernatants above control, and are averages of duplicates ± range. The experiments were
repeated 2-3 times.

Figure 15 shows that anti-CD45 also increased production of TN Fa from cells
treated with MPL-s, one of the CD 14 ligands.
Finally, anti-CD 14 UCHM-1 activates AA release from THP-1 cells, and may
serve as an LPS agonist, directly activating signaling by binding to the LPS-binding site on
CD 14. Isotype-matched control IgCna was shown to have no effect on AA release (Fig.
6). To further confirm its role as an LPS agonist, I was able to show that, like LPS, anti-
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CD 14 UCHM-1 induced only PGE2 and not LTC» production, giving high PGE2/LTC4
ratios (Fig. 16), was able to desensitize cells to LPS challenge (Fig. 17), and had very little
effect on cells without D3 pretreatment (Fig. 18). Figure 18 also shows that anti-CD45
significantly increased AA release from cells treated with anti-CD 14.
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Figure 15. aCD45 increased release of T N Fa from THP-1 cells challenged with
MPL-s. D3-pretreated THP-1 cells were challenged for 20 hr with MPL-s at
concentrations shown, with or without aCD45 2D1. Supernatants were assayed for
TNFa by ELISA according to Quantikine instructions. TNFa in pg/ml was calculated
from a standard curve.
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Control

LPS Anti-CD14

Figure 16. aC D 14 UCHM-1 induced PGE 2 production. Supernatants from D3pretreated THP-1 cells that had been challenged with aCD14 UCHM-1 were assayed for
PGE2 and LTC4 using EIA, according to manufacturer’s instructions. PGE2 & LTC4 in
pg/ml were calculated from standard curves. Values are molar ratios o f PGE2 to LTC4 .
and are averages o f duplicates ± range.
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Figure 17. Desensitization of THP-1 cells with aCD14. D3-pretreated THP-1 cells
were treated with medium alone or 1 jig/ml aCD14 UCHM-1 for 2 hrs. Cells were then
washed and labeled overnight with 3H-AA. They were washed again and challenged in 24
well plates (5x10s cells/ml) with LPS R595 for 2 hr. 200 ^1 of cell-free supernatants were
counted. Values represent cpm released above control, and are averages o f duplicates.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

109

feasfead Control (no anti-CD4S)
anti-CD45
*

1

Ui

oe

1400 -

1200

-

1000

*

400 -

No D3
aCD14

D3
aCD14

No D3

D3

•9 ^ 2 1

■SG2a

Figure 18. Vitamin D3 pretreatm ent increased the sensitivity of THP-1 cells to
challenge with aCD14, and the effect of aCD45. THP-1 cells, D3 treated or untreated,
were labeled and challenged with aCD14 UCHM-1, with or without aCD45 2D1, for 2
hr. Values represent cpm released in 200 |ji of cell-free supernatants above control, and
are averages o f duplicates ± range.

LPS treatm ent caused increased phosphorylation of CD45. The
phosphorylation o f tyrosines on CD45 has been shown to modify PTPase activity. The
terminal PTPase domain on CD45 appears to be an autodephosphorylation activity (102).
In order to determine whether LPS or anti-CD45 mAb affected PTPase activity, the
phosphorylation o f CD45 was compared under various conditions using anti-
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phosphotyrosine mAbs to stain immunoblots o f CD4S immunoprecipitates from lysed
THP-1 cells. There was an apparent transient increase in the phosphotyrosine stain after 5
minutes o f incubation with LPS (Fig. 19).
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Figure 19. LPS increased phosphorylation of CD45 within 15 min after treatment.
D3-pretreated THP-1 cells were treated with LPS for 0, 5, 15, 30, and 45 min (lanes 2-6),
and then lysed in lysis buffer containing NaV04 and PhAsO to inhibit further PTPase
activity. Lysates were immunoprecipitated with aCD45 as described in Materials &
Methods, and run on 7.5% SDS-PAGE mini-gels. These were then blotted onto PDVF
membranes and stained with biotinylated aphosphotyrosine mAb. The immunoblots were
developed and films exposed using ECL. Lane 1, Protein standard; Lane 7, positive
control.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

I ll

DISCUSSION
The data reported provide indirect evidence for a role o f the CD45 protein
tyrosine phosphatase in signaling activated by LPS through CD 14. More direct evidence
could be obtained by using CD45 knock-out mutants. Our inquiries regarding CD45
knock-out mice or monocyte cell lines were regrettably unsuccessful. Despite the
limitations o f indirect studies, however, this is the first study to show any relationship
between CD4S and signaling for arachidonic acid release, or specifically via CD 14.
Studies on T cells have now been done that provide both indirect (using mAbs) and direct
(using CD45 knock-outs) evidence of CD45 involvement in regulation o f signaling
(reviewed in (93)). Tyrosine kinases of the src family in CD45-deficient T cells are
hyperphosphorylated on tyrosines at inhibitory sites. In these cases, CD4S activates the
kinases by removing the phosphate groups from these sites. Because this occurs in resting
cells, CD4S apparently serves to maintain a state of readiness prior to TCR-antigen
binding. This also implies that CD45 must be in close proximity to these substrates even
in resting cells. This is consistent with our data showing constitutively high expression of
CD4S on resting cells. Some tyrosine kinases are inactivated by removal o f phosphates
from positive regulatory sites, so that CD4S can also be a down-regulator of tyrosine
kinase activity.
Consistent with this model in T cells, tyrosine kinases appear to be the substrates
for dephosphorylation by CD4S in monocytes, and this activity regulates signal
transduction (61,77). Signaling through CD14 activates tyrosine phosphorylation (60),
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and tyrosine phosphorylation activated by LPS is associated with release of arachidonic
acid metabolites (33). This suggests the possibility that signaling by LPS through CD14
activates arachidonic acid metabolism via a tyrosine kinase signaling cascade. This study
was undertaken to determine whether CD45 protein tyrosine phosphatase plays a role in
regulating that pathway. As suggested in the T cell model, CD45 may simply maintain a
state o f readiness by keeping tyrosine kinases from being phosphorylated at inhibitory
sites. This is supported by the fact that addition o f anti-CD45 18 hours before challenge
had a greater effect than addition just prior to challenge (Fig. 4a,b), that anti-CD45 had
little effect by itself (Fig. S), and by the fact that anti-CD45 had no effect on
desensitization by LPS (Fig. 9). Cross-linking of anti-CD45 appears to have inhibited the
phosphatase activity, so that tyrosine kinase signaling was inhibited by phosphorylation
(Fig- 8).

The possibility that some o f the effects seen were due to binding of anti-CD45 to Fc
receptors was considered. However, isotype matched control mAbs had no effect (Fig.
5). Also, activation by anti-CD45 and LPS led to production of PGE2, but not LTB4 or
LTC4, consistent with other studies showing that LPS only activates cyclo-oxygenase and

not 5’-lipoxygenase (31,33,105), and suggests that anti-CD45 simply increased signaling
by LPS, but did not activate other pathways. Activation through FcRy has been shown to
lead to production of LTB4 from neutrophils and monocytes (49,83).
Several lines of evidence were used to link these effects o f anti-CD45 with
signaling through CD 14. First, it was shown that there was little effect with no serum in
the challenge medium (Fig. 11). Signaling via CD 14 by LPS requires a serum LPS binding

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

113

protein, LBP, for transfer o f monomers to CD14 (70,108). Absence of LBP reduces
cellular sensitivity to LPS, but LPS can still signal via CD 14-independent pathways (68).
The reduced effect of anti-CD45 in medium without serum suggests that CD45 may be
more active in regulating CD 14-dependent signaling than CD 14-independent signaling.
Similarly, pretreatment o f the cells with vitamin D3, which increases expression o f CD 14
(see Chapter 2) also increased the effect o f anti-CD45 (Fig. 12). Without D3
pretreatment, anti-CD45 had almost no effect except at the highest LPS concentration.
Finally, other CD 14 ligands, including MPL, DPL, LTA, and an LPS agonist mAb
to CD 14, also were much more potent for AA release in the presence of anti-CD45 (Fig.
13). However, none o f the activating agents that do not bind CD14 showed this
synergistic effect with anti-CD45 (Fig. 14.)
There is evidence in T cells that engagement of the extracellular domain o f CD45 by
other glycosylated cell surface molecules such as adhesion molecules (or CD45-specific
mAbs) can modify the protein tyrosine phosphatase activity of the cytosolic domain (93).
We attempted to visualize changes in the phosphorylation state o f CD4S before and after
treatment with LPS, since autodephosphorylation is an indication of PTPase activity
(102). This would provide a more direct connection between LPS signaling and CD45.
On my initial immunoblots, there was an apparent increase in phosphorylation o f CD4S at
5 min after stimulation o f the cells with LPS (Fig. 19). These experiments need to be
repeated and carefully standardized for the amount o f protein/well, and then analyzed by
densitometry. This assay could then be expanded to look at the kinetics o f
autodephosphorylation o f CD45, and the effects of this change in activity on function in
terms o f activation and desensitization of the arachidonic acid metabolism pathway.
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Tyrosine phosphorylation has been correlated with all indices o f macrophage
activation studied so far (24,32-34,37,53,99). Although CD45 appears to play a role in
LPS signaling, the broad range of pathways affected by CD45 in macrophages
(39,53,61,64,77,101) suggests the possibility that CD45 does not specifically associate
with any particular receptor. It may instead affect generalized signaling via src family
protein tyrosine kinases (PTK) by maintaining the phosphoiylation-dephosphorylation
equilibrium at a level that ensures readiness to respond through any pathways utilizing a
PTK cascade. If this is the case, it may be possible to reduce sensitivity of macrophages
to multiple signals by inactivating CD45. CD45-deficient systems could be used to study
this. However, our cross-linking studies suggested that cross-linking CD45 molecules
may inhibit the PTPase activity. If cross-linking CD45 during a desensitization period
could block response to subsequent challenge with LPS, this would also support the
readiness hypothesis. This may therefore be critical to understanding the desensitization
phenomenon. It could also provide a mechanism for down-regulation o f macrophage
activation as a potential therapeutic model. It is along these lines that future studies are
being designed.
It was also interesting that in experiments using conditions that favored CD 14independent signaling, there was a consistent slight to moderate reduction in AA release,
rather than the increase seen with CD 14 ligands. Further studies would need to be done
to look at the statistical significance of these reductions. If they were significant
reductions, it would be interesting to look at the possibility that CD45 regulates these
signaling pathways as well, but in these cases it decreases responsiveness. At least two
models are conceivable. First, the kinases involved in CD 14 independent pathways may
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become phosphorylated on activation sites rather than inhibitory sites, so that CD4S
PTPase activity inactivates them. This leads to a conceptual model of a single regulatory
system (CD45 dephosphorylation o f kinases) that serves to activate some pathways while
at the same time inactivating others. This would ensure patterns o f responses depending
on the type o f stimuli present. Another possibility is a kinetic model in which early
signaling pathways are maintained in a state of readiness by the constitutive activity of
CD4S, but binding o f a ligand to a receptor in proximity to the extracellular domain of
CD45 may alter that activity. Activation of later signaling pathways might then be
inhibited due to this change in PTPase activity which may no longer maintain the state of
readiness to respond. These models could be explored using a phosphatase assay to
determine activity o f the CD45 PTPase before and after challenge. We are developing a
colorimetric assay for looking at PTPase activity on immunoprecipitates of CD4S.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

CHAPTER 6
CONCLUSIONS AND FUTURE STUDIES

Elucidation of signal transduction pathways in macrophages will not only
improve our overall understanding of these complex and critical players in immune
responses, but also may expose exploitable mechanisms for treatment or prevention o f
conditions caused by immune dysfunction. These studies were undertaken to explore
three steps of signal transduction as they relate to LPS activation of macrophages:
1. Recognition of LPS by cells, including factors affecting cellular sensitivity,
2. Signaling components in the activation o f arachidonic acid by LPS, and
3. Regulatory mechanisms modulating arachidonic acid metabolism.
It was first necessary to characterize a monocyte/macrophage cell system in order to
maximize consistency and reproducibility o f results, and to rule out effects o f the
treatments o f other parameters of cellular responses such as viability, receptor expression,
and lipid pool labeling. The studies reported in Chapter 2 demonstrate that vitamin D3pretreated THP-1 monocytic cells provided an excellent cell system for studies on
arachidonic acid metabolism.
Macrophages recognize LPS in at least two ways. The primary signaling receptor for
LPS is CD 14, a glycosylphosphatidylinositol-linked protein that has been shown to be
involved in the activation of protein tyrosine kinases and several signaling pathways.
LPS also activates cells in a CD 14-independent manner, either by some other receptor or
by non-specific interaction with the membrane. It has also been proposed that cells
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recognize LPS as a mimic o f an important intracellular second messenger, ceramide. The
work presented in Chapter 3 explored relative potencies o f several bacterial amphiphiles,
most o f which have also been shown to bind CD 14, and yet can have very different
effects. These data, along with current literature, were used to develop a model o f
sensitivity o f macrophages to LPS based on supramolecular structure and aggregate
stability. Binding to CD 14 requires presentation as monomers carried by LPS binding
proteins. Inaccessibility of monomers to LBP due to supramolecular structure would
limit signaling through this pathway. However, aggregate structure might affect CD 14independent signaling very differently than CD 14-dependent signaling, so that various
amphiphiles might activate the two pathways with very different frequencies, resulting in
varying potencies and potentially unique overall responses. This could explain why some
LPS preparations are quite toxic while others can be protective in vivo. This work in on
going through a collaboration with Ribi ImmunoChem Research.
Chapter 4 explored the LPS/ceramide mimicry model in terms o f arachidonic acid
metabolism. This model provides a basis for studying not only the recognition of cells by
LPS, but also of several signaling components involved in macrophage activation by
LPS. The results presented in Chapter 4 showed that the mimicry o f ceramide by LPS is
not simple, and although they may share some signaling components, LPS has unique
functions including the ability to desensitize cells to subsequent challenge and the
activation o f cyclo-oxygenase. There is a possibility that these two functions are related
due to an autocrine effect by prostaglandin or another product related to the cyclooxygenase activation. Future studies will be looking at other lipids released by activated
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macrophages, and through the use o f creative co-culture experiments it will be possible to
further investigate the possible autocrine/paracrine effects by released mediators. These
studies will be especially important in view o f recent evidence that massive endothelial
apoptosis in the microvasculature o f multiple organs plays an important role in the
pathogenesis of septic shock. Ceramide has been shown to be an inducer o f apoptosis,
and it is released in cells activated by TNFa. This raises the possibility that LPS may not
only activate the release o f TNFa, but may also further exacerbate the apoptotic events
through mimicry o f ceramide.
The desensitization phenomenon is intriguing, and the mechanism remains unknown.
As mentioned above, there may be an autocrine factor involved. However, even that
would not explain what exactly occurs inside the cell to create the refractory state
prohibiting further activation of the cell by LPS. Activation and desensitization have
both been associated with the activity o f protein tyrosine kinases and could therefore be
functions o f the phosphorylation-dephosphorylation dynamics o f these enzymes. Many
protein tyrosine kinases are regulated by their own phosphorylation state. In T cells,
CD4S deficient mutants are hyperphosphorylated on the src family PTKs, and are unable
to respond to antigen binding by the TCR. This provides a model in which
hyperphosphorylation causes a refractory, or desensitized state. In order to explore a
similar mechanism for desensitization in macrophages, it was hypothesized that CD4S
might also maintain a state of readiness to respond by dephosphorylating the src PTKs
involved in signaling via CD 14. Using anti-CD45 mAbs, it was demonstrated that CD4S
does play a role in the activation o f arachidonic acid metabolism by LPS. The lack o f a
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CD45-deficient macrophage cell system or an anti-CD45 mAb that blocked the PTPase
activity prevented a careful exploration o f the role of CD45 in the desensitization
phenomenon. However, cross-linking of CD45 appeared to inhibit the PTPase, and
preliminary studies showed that this also desensitized cells to subsequent challenge. This
would suggest that blocking CD4S activity prevented the state of readiness to respond by
allowing tyrosine phosphorylation on inhibitory sites o f the PTKs. However, several
more studies would need to be done to determine whether this is also part of mechanism
o f LPS desensitization.
In summary, three mechanisms of modulating responsiveness to LPS have been
examined, including modification o f the supramolecular structure of LPS preparations, an
autocrine or paracrine effect related to activation o f the cyclo-oxygenase pathway, and
alteration o f the phosphorylation state of PTK signaling cascades. Exploitation of these
mechanisms may be possible, and may prove to be therapeutic or prophylactic for
pathological conditions resulting from excessive inflammation or other immune
dysfunction. Applications may include treatment o f asthma, septic shock, cardiac
ischemia/reperfiision injury, organ transplants, and atherosclerosis.
The outcome of any set o f conditions in a cell or tissue appears to depend not on a
linear progression of events, but on the relative frequency o f many related events. For
example, whether a signal results in mitogenesis or cell cycle arrest appears to depend on
the intracellular ratio of two important second messengers with opposing effects:
diacylglycerol and ceramide. Also, the activation of tyrosine kinases appears to be due to
the relative amount of phosphorylation o f the entire cascade, not a simple on/off switch.
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The ratio of prostaglandins and leukotrienes appears to be critical in the overall
inflammatory response in a given situation, rather than simply the presence o f one or the
other. Apoptosis is being exposed as a very important part of many processes including
beneficial ones (selection o f an appropriate set of T cells that survive development in the
thymus, destruction o f cancerous cells, and embryonic development), and harmful ones
(destruction of tissue in septic shock, heart attack, etc). It is known that TN Fa is an
important inducer o f apoptosis, but the identity of the molecule that balances that effect is
unknown. It seems very possible that it might be revealed by these continuing studies on
the modulation of macrophage activation.
The findings presented in this thesis provide clues to the complexities o f LPSinduced signal transduction in macrophages, but the picture is far from complete. The
systems of checks and balances for maintaining an effective and appropriate response to
bacterial infection without causing undue damage are intertwined in a dynamic network.
This prohibits simple answers, and consistently provides more questions with every step
forward. In the 1960’s, Ivan L. Bennett, Jr., working at Johns Hopkins, expressed both
the fascination and frustration researchers face in these complex systems:
“Endotoxins possess an intrinsic fascination that is nothing less than fabulous.
They seem to have been endowed by nature with virtues and vices in the exact and
glamorous proportions needed to render them irresistible to any investigator who comes
to know them.” (78).
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